• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

K
k. Yoo S.	-	IMMUNE TOLERANCE INDUCTION FOR KOREAN HEMOPHILIACS WITH INHIBITORS
	-	INTERMEDIATE-DOSE PROPHYLAXIS EXPERIENCE FOR KOREAN HEMOPHILIA PATIENTS
Kaabache T.	-	EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS)
Kaabachi N.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Kaaja R.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Kaasjager K.	-	ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME
Kaatz S.	-	EFFECT OF SURGICAL PROCEDURES AND SPECIFIED RISK FACTORS ON THE INCIDENCE OF PERI-OPERATIVE STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF)
	-	COMPARISON OF THE 30-DAY INCIDENCE OF ISCHEMIC STROKE AND BLEEDING AFTER MAJOR SURGERY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION (AF)
	-	THROMBOEMBOLISM AND BLEEDING OUTCOMES OF LOW-MOLECULAR-WEIGHT HEPARIN BRIDGING THERAPY DURING PERI-PROCEDURE WARFARIN INTERRUPTION: PATIENT-LEVEL POOLED DATA OF FOUR COHORT STUDIES
	-	UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY
Kabakus N.	-	INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B
Kabrhel C.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Kachnowski S.	-	OPTIMIZING CARE VIA INTERNET-BASED HEMOPHILIA THERAPY MANAGEMENT PLATFORM
Kada A.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Kadar J.	-	PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
Kadar J.G.	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Kadegasem P.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
Kadinskaya M.I.	-	SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE
Kadir R.A.	-	MENORRHAGIA ASSOCIATED WITH LABORATORY ABNORMALITIES OF HEMOSTASIS: EPIDEMIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS
Kadir R.	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Kadir R.A.	-	LONG TERM FOLLOW-UP OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN THE MANAGEMENT OF MENORRHAGIA IN WOMEN WITH INHERITED BLEEDING DISORDERS
	-	POSTPARTUM LOCHIAL LOSS IN WOMEN WITH INHERITED BLEEDING DISORDERS
Kadohira Y.	-	PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
	-	CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
Kadota K.	-	CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
Kaegi E.	-	SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS
Kagawa K.	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Kaguelidou F.	-	PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Kahan T.	-	DOES ANGIOTENSIN II HAVE PROINFLAMMATORY OR PROTHROMBOTIC EFFECTS?
Kahn S.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Kahn S.R.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Kahn M.L.	-	RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI
Kahn S.	-	RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
Kahn S.R.	-	INHERITED THROMBOPHILIA AND PREECLAMPSIA WITHIN A COHORT OF 5337 WOMEN: RESULTS OF THE MONTREAL PREECLAMPSIA STUDY
Kahn S.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Kahn S.R.	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
	-	WARFARIN USE AND THE DECREASED RISK OF PROSTATE CANCER
	-	FREQUENCY OF "SPECIAL POPULATION" CHARACTERISTICS IN VENOUS THROMBOEMBOLISM PATIENTS IN CLINICAL PRACTICE: EFFECT ON PATIENT MANAGEMENT
	-	INTER-OBSERVER RELIABILITY OF MEASURES TO ASSESS THE POST-THROMBOTIC SYNDROME (PTS)
	-	A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
	-	LONG TERM OUTCOME AFTER DEEP VEIN THROMBOSIS
	-	PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
	-	POST-THROMBOTIC SYNDROME AFTER VENA CAVA FILTER PLACEMENT: A SYSTEMATIC REVIEW
	-	THE EFFECT OF ANTICOAGULANTS ON CANCER RISK AND SURVIVAL: SYSTEMATIC REVIEW
	-	ELEVATED PLASMA GAS6 LEVELS ARE ASSOCIATED WITH CLOT BURDEN AND UNDERLYING MALIGNANCY IN DEEP-VEIN THROMBOSIS
Kahr W.	-	THE EFFICACY AND SAFETY OF ANTITHROMBIN CONCENTRATE IN CHILDREN RECEIVING HEPARIN INFUSIONS
Kahr W.H.	-	PLATELET FUNCTION THROMBOELASTOGRAPHY (PFT)
	-	DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
Kahraman S.	-	THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Kaider A.	-	P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
Kaijen P.H.P.	-	FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A
Kain K.	-	ALANINE AMINOTRANSFERASE, ATHEROTHROMBOTIC RISK FACTORS AND METABOLIC SYNDROME IN SOUTH ASIANS
Kaiser R.	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
Kaiser B.	-	ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
	-	ARGATROBAN IS CAPABLE OF PASSING THROUGH THE BLOOD BRAIN BARRIER. POTENTIAL IMPLICATIONS IN THE MANAGEMENT OF THROMBOTIC STROKE
Kaiser T.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Kakkar V.V.	-	APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
Kakkar A.K.	-	SEX DIFFERENCE IN PLASMA SENSITIVITY TO TISSUE FACTOR RELATES TO THE LEVELS OF CIRCULATING PLATELET-DERIVED MICROPARTICLES
Kakkar V.V.	-	SEX DIFFERENCE IN PLASMA SENSITIVITY TO TISSUE FACTOR RELATES TO THE LEVELS OF CIRCULATING PLATELET-DERIVED MICROPARTICLES
Kakkar A.K.	-	SYNERGISTIC EFFECT OF HEPARIN, LOW MOLECULAR WEIGHT HEPARIN AND PACLITAXEL ON CYTOTOXICITY FOR BREAST CARCINOMA CELLS IN CULTURE
	-	THE INHIBITORY ACTIVITY OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ON BREAST CARCINOMA CELL LINES
Kakkar V.	-	DENDROASPIN, AN RGD-CONTAINING SNAKE VENOM PROTEIN INITIATES ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A2-ALPHA ACTIVATION
	-	RGD-CONTAINING DENDROASPIN, RGD PEPTIDE AND DDM PEPTIDE INDUCE APOPTOSIS OF JURKAT CELLS
Kakkar V.V.	-	CHLAMYDIA PNEUMONIA INFECTION AND ITS RELATION TO LIPIDS AND INFLAMMATORY MARKERS IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
	-	ROLE OF NOVEL LIPOPROTEIN-ASSOCIATED INFLAMMATORY MARKERS IN CORONARY ARTERY DISEASE: A PILOT STUDY
	-	SERUM ADIPONECTIN LEVELS & ITS CORRELATION WITH LIPIDS AND PROINFLAMMATORY MARKERS IN ASIAN INDIAN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
Kakkar A.K.	-	LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
	-	AT LOW CONCENTRATIONS OF TISSUE FACTOR, CIRCULATING MICROPARTICLES CAUSE A MARKED SHORTENING OF THE RECALCIFICATION TIMES OF PLASMA FROM NORMAL HEALTHY INDIVIDUALS
	-	MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS HEPARIN SENSITIVE PEAKS IN THE SERUM PEPTIDOME OF NORMAL HEALTHY INDIVIDUALS
	-	MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS PEAKS ARE DIFFERENT IN THE SERUM PEPTIDOME IN COMPARISON TO THE PLASMA PEPTIDOME
	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC BLOOD BASED APPROACH
	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC CELL-BASED APPROACH
Kakkar V.V.	-	PLASMA LEVELS OF COAGULATION AND INFLAMMATORY MARKERS IN SUBJECTS AFFECTED WITH CORONARY ARTERY DISEASE
	-	PATHOGEN BURDEN AND CORONARY ARTERY DISEASE
	-	ASSOCIATION OF CYTOMEGALOVIRUS (CMV) AND PROATHEROGENIC BIOMARKERS IN CORONARY ARTERY DISEASE (CAD)
Kakkar V.	-	INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
Kakkar V.V.	-	FVII ACTIVITY AND R353Q POLYMORPHISM IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE
	-	CORRELATION OF METABOLIC SYNDROME WITH ATHEROGENIC PHENOTYPES IN INDIAN POPULATION
Kakkar A.K.	-	VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
	-	HEPARIN TREATMENT INCREASES TYROSINE PHOSPHORYLATION OF PROTEINS IN BREAST CANCER CELLS: DIFFERENCES IN THE EFFECT OF LMWH AND UFH
Kakkar V.V.	-	POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY
	-	CONSIDERATION OF MODIFIED CUT-OFFS FOR ANTHROPOMETRIC VARIABLES IN DEFINING METABOLIC SYNDROME AMONG ASIAN INDIANS WITH CORONARY ARTERY DISEASE (CAD)
Kakkar V.	-	DETERMINATION OF THE INTEGRIN BINDING PROPERTIES OF THE PUTATIVE INTEGRIN-BINDING MOTIFS OF ADAM PROTEINS USING MUTANTS BASED UPON A DENDROASPIN SCAFFOLD
	-	SELECTIVE BINDING TO INTEGRIN ALPHA-9-INTEGRIN EXPRESSING CELLS OF MUTANTS OF DISINTEGRIN-LIKE DOMAIN OF ADAM-15 CONTAINING THE PUTATIVE INTEGRIN BINDING MOTIF OF ADAM-2, -12 AND -19, RESPECTIVELY
Kakkar V.V.	-	CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
Kakkar A.	-	BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
Kakkar V.V.	-	HERITABILITY OF C-REACTIVE PROTEIN AND INTERLEUKIN 6 AMONG THE ASIAN INDIAN POPULATION
	-	APOA1 PROMOTER POLYMORPHISMS AND THEIR ASSOCIATION WITH LIPOPROTEINS IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE (CAD)
Kakusaka M.	-	COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
Kalafatis M.	-	THE ROLE OF THE ACIDIC COOH-TERMINAL REGION OF FACTOR VA HEAVY CHAIN DURING ACTIVATION OF PROTHROMBIN BY PROTHROMBINASE
	-	CHARACTERIZATION OF A PENTAPEPTIDE THAT MODULATES PROTHROMBINASE ACTIVITY
	-	ALLOSTERIC REGULATION OF PROTHROMBIN ACTIVATION BY FACTOR VA
	-	CONTRIBUTION OF ASP334 AND TYR335 OF FACTOR VA TO PROTHROMBINASE FUNCTION
	-	IDENTIFICATION OF A BINDING SITE FOR FACTOR XA ON THE LIGHT CHAIN OF FACTOR VA
	-	THE INTERACTION OF PROTHROMBIN WITH THE MEMBRANE SURFACE IS A PREREQUISITE FOR OPTIMUM EXPRESSION OF FACTOR VA COFACTOR ACTIVITY WITHIN PROTHROMBINASE
	-	ISOLATION AND CHARACTERIZATION OF AN ANTI-FACTOR VIII ANTIBODY FROM A PATIENT WITH ACQUIRED HEMOPHILIA
Kalal K.K.	-	ARTERIAL STIFFNESS, ENDOTHELIAL FUNCTION AND THE RISK OF ISCHAEMIC STROKE
Kalashnikova E.A.	-	PREVALENCE OF FACTOR V LEIDEN, PROTHROMBIN G20210A, AND 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE MUTATIONS IN A HEALTHY RUSSIAN POPULATION
Kalchenko V.	-	PRO- AND ANTI-ANGIOGENIC CYTOKINES ARE CONDITIONALLY AND SELECTIVELY RELEASED FROM ALPHA-GRANULES UPON PLATELET STIMULATION
Kaldus T.	-	P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
Kalippke K.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Kallas A.	-	IMMUNE RESPONSE TO ADMINISTRATION OF PLASMA-DERIVED COAGULATION FACTOR VIII IN FACTOR VIII-DEFICIENT MICE
Kallel H.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Kallner A.	-	COMPARISON OF THREE DIFFERENT TAFI ASSAYS IN PATIENTS WITH ACUTE CORONARY SYNDROME
	-	MEASUREMENTS OF FIBRINOGEN AND CRP CONCENTRATIONS IN EDTA AND CITRATE PLASMA
Kallwellis-Opara A.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Kalo M.S.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
Kalra R.	-	Common thrombophilias in 85 Indian patients with arterial thrombosis
Kalus U.	-	EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII (NOVOSEVEN) IN TRAUMA AND SURGERY PATIENTS WITH MASSIVE BLEEDING A REGISTER ANALYSIS
Kamada H.	-	REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Kamae T.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Kamal N.R.	-	INHERITED BLEEDING DISORDERS- A 14 YEAR RETROSPECTIVE STUDY
Kambayashi J.	-	FUNCTIONAL ANALYSIS OF ANTI-GPVI MONOCLONAL ANTIBODIES WITH DISTINCT BINDING SITES
	-	EPITOPE MAPPING OF COLLAGEN BINDING SITE IN HUMAN GLYCOPROTEIN VI (GPVI)
	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Kamide K.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Kaminska M.	-	DIAMOND PARTICLES OF MICROMETRIC SIZE ARE INTERNALIZED BY ENDOTHELIAL CELLS
Kaminsky P.	-	SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Kammerer I.	-	FV LEIDEN, THE APOE GENOTYPE AND OTHER GENE POLYMORPHISMS IN PATIENTS UNDERGOING CARDIAC SURGERY
Kampagianni O.	-	HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL
Kamphuisen P.W.	-	CANCER AND THROMBOSIS: FROM MOLECULAR MECHANISMS TO CLINICAL PRESENTATIONS
Kamphuisen P.P.W.	-	OVERWEIGHT IN DUTCH HAEMOPHILIA PATIENTS
Kamphuisen P.W.	-	CARDIOVASCULAR RISK FACTORS AND VENOUS THROMBOEMBOLISM: A META-ANALYSIS
Kanakura Y.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Kane W.H.	-	THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
Kaneda Y.	-	THE PHARMACOLOGICAL PROFILE OF DZ-697B, A NOVEL ANTI-PLATELET AGENT
Kaneko M.	-	SYNERGISM BETWEEN GI ACTIVATION AND CA2+ MOBILIZATION IN PLATELET THROMBOXANE A2 FORMATION
Kanellopoulou G.	-	SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
Kang M.M.S.	-	EARLY DIAGNOSIS OF SEPTIC DISSEMINATED INTRAVASCULAR COAGULOPATHY
Kang C.	-	DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL
Kang M.	-	ANALYSIS OF EFFECTS OF METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) POLYMORPHISMS ON HOMOCYSTEINE CONCENTRATION AND RECURRENT SPONTANEOUS ABORTION IN KOREANS
Kang S.Y.	-	IMMUNE TOLERANCE INDUCTION FOR KOREAN HEMOPHILIACS WITH INHIBITORS
Kang H.	-	MONITORING OF PLATELET FUNCTION AFTER CLOPIDOGREL TREATMENT
Kang S.	-	THE INHIBITORY ACTIVITY AND MECHANISM OF BUD-030, A NOVEL INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
Kang M.M.S.	-	CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Kang C.	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
Kanidis A.	-	COINHERITANCE OF FV-LEIDEN MUTATION AND FV-HR2
Kanjilal S.	-	CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
	-	CORRELATION OF METABOLIC SYNDROME WITH ATHEROGENIC PHENOTYPES IN INDIAN POPULATION
	-	CONSIDERATION OF MODIFIED CUT-OFFS FOR ANTHROPOMETRIC VARIABLES IN DEFINING METABOLIC SYNDROME AMONG ASIAN INDIANS WITH CORONARY ARTERY DISEASE (CAD)
	-	HERITABILITY OF C-REACTIVE PROTEIN AND INTERLEUKIN 6 AMONG THE ASIAN INDIAN POPULATION
	-	APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
	-	SERUM ADIPONECTIN LEVELS & ITS CORRELATION WITH LIPIDS AND PROINFLAMMATORY MARKERS IN ASIAN INDIAN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
	-	CHLAMYDIA PNEUMONIA INFECTION AND ITS RELATION TO LIPIDS AND INFLAMMATORY MARKERS IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
	-	ASSOCIATION OF CYTOMEGALOVIRUS (CMV) AND PROATHEROGENIC BIOMARKERS IN CORONARY ARTERY DISEASE (CAD)
	-	PLASMA LEVELS OF COAGULATION AND INFLAMMATORY MARKERS IN SUBJECTS AFFECTED WITH CORONARY ARTERY DISEASE
Kannan S.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Kannan R.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Kannicht C.	-	PRODUCT FEATURES OF THE NOVEL GENERATION VWF/FVIII CONCENTRATE IN A COMPARISON WITH FIRST GENERATION PRODUCTS
	-	VON WILLEBRAND FACTOR (VWF)-BINDING TO COLLAGEN III UNDER PHYSIOLOGICAL FLOW CONDITIONS AND VWF-MEDIATED PLATELET BINDING
	-	A PHARMACEUTICALLY LICENSED SOLVENT/DETERGENT (S/D) TREATED PLASMA AND A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT IN TTP AND HUS: QUANTIFICATION OF ADAMTS13 AND FACTOR H LEVELS
Kannno Y.	-	2-AG PLAY A ROLE ON ASPIRIN RESISTANCE IN TYPE 2 DIABETES
Kanno N.	-	SYNERGISM BETWEEN GI ACTIVATION AND CA2+ MOBILIZATION IN PLATELET THROMBOXANE A2 FORMATION
Kanse S.M.	-	STRUCTURE-FUNCTION ANALYSIS OF THE BINDING PROPERTIES AND ENZYMATIC ACTIVITY OF FACTOR VII ACTIVATING PROTEASE (FSAP) USING RECOMBINANT MUTANT PROTEINS
	-	THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS
	-	FACTOR VII ACTIVATING PROTEASE (FSAP) REGULATES CELL ADHESION AND MOTILITY BY MULTIPLE MECHANISMS
	-	FACTOR VII ACTIVATING PROTEASE (FSAP)
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED PROGENITOR CELL HOMING AND DIFFERENTIATION INTO ENDOTHELIAL CELLS
	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
	-	THE UROKINASE SYSTEM REGULATES THE MOBILIZATION, HOMING AND DIFFERENTIATION OF PROGENITOR CELLS INTO ENDOTHELIAL CELLS
	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
	-	INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
Kapelak B.	-	CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
	-	C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Kaplan C.	-	PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
	-	NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Kaplan V.	-	COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING
Kaplan M.	-	INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B
Kaplan C.	-	GPIIB-IIIA INTEGRIN MUTATIONS IDENTIFIED IN 19 GLANZMANN THROMBASTENIC PATIENTS AND 3 CARRIERS
Kaplanski G.	-	UNIQUE RECIPROCAL MAP KINASE REGULATION IN THROMBIN-INDUCED ENDOTHELIAL PRO-INFLAMMATORY ACTIVATION
Kappel A.	-	QUANTITATION OF D-DIMER BY LOCI TECHNOLOGY
Kappelmayer J.	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
	-	GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS
	-	ANALYSIS OF SURFACE AND SOLUBLE L-SELECTIN IN RELATION TO FLOW CYTOMETRIC PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Kappert G.	-	NORMAL VALUES FOR FACTOR VII ACTIVITY IN NORMAL PREGNANCY AND IN THE PREGNACY OF WOMEN WITH CONGENITAL FACTOR VII DEFICIENCY
	-	PAEDIATRIC REFERENCE RANGES FOR COAGULATION DIAGNOSTICS
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
Kapsali H.	-	ON THREE CASES OF INHERITABLE FACTOR VII DEFICIENCY
Kapustin S.I.	-	APOE GENE POLYMORPHISM CAN MODIFY THE RISK OF VENOUS THROMBOEMBOLISM
	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
	-	THE ROLE OF DNA POLYMORPHISMS IN GENES CODING THE HOMOCYSTEINE AND FOLATE METABOLIZING ENZYMES IN ISCHAEMIC HEART DISEASE
	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH PREGNANCY LOSS AND GESTATIONAL OUTCOME IN WOMEN WITH DIAGNOSED THROMBOPHILIA FOLLOWING ANTITHROMBOTIC THERAPY
	-	HYPERHOMOCYSTEINEMIA AND FACTOR V LEIDEN ACT SYNERGISTICALLY INCREASING RISK OF VEIN THROMBOSIS IN NORTH-WESTERN RUSSIA
Käpylä J.	-	PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Karabasova M.A.	-	HAEMOSTASIS AND FIBRINOLYSIS AFTER EXPERIMENTAL AUDIOGENIC SEIZURES/
Karafoulidou A.	-	SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
	-	COAGUCHEK XS IN COMPARISON TO BCS ANALYZER. RESULTS IN AN OUTPATIENT ANTICOAGULATION CLINIC, FOCUSED IN METAL VALVE DISEASE
	-	CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
	-	PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY
	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Karagianni P.	-	HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Karahan Yesil N.	-	LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS
Karakantza M.	-	FV LEIDEN, FII G20210A AND MTHFR T677T GENOTYPES: IS THEIR EVALUATION A USEFUL TOOL IN THE ETIOLOGICAL APPROACH OF THE EARLY RECURRENT PREGNANCY LOSSES IN THE GREEK POPULATION?
	-	INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE
Karami Djurabi R.	-	PULMONARY EMBOLISM FAILURE RATE IN PATIENTS IN WHOM PULMONARY EMBOLISM WAS RULED OUT BY LOW AND INTERMEDIATE PROBABILITY BY THE REVISED GENEVA SCORE AND A NORMAL QUANTITATIVE D-DIMER TEST RESULT
	-	FACTOR V LEIDEN IS ASSOCIATED WITH MORE DISTAL LOCATION OF DEEP VEIN THROMBOSIS OF THE LEG
Karanfilski O.	-	INTENSIVE PLASMA EXCHANGE WAKES UP PATIENT WITH TTP IN COMA
Karapetian H.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Karbasy M.	-	THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL
Karbovskyy V.L.	-	ISOLATION AND CHARACTERIZATION OF PLASMINOGEN-ACTIVATING PROTEINASE FROM AGKISTRODON HALYS HALYS VENOM
	-	ISOLATION AND CHARACTERIZATION OF PLASMINOGEN-ACTIVATING PROTEINASE FROM AGKISTRODON HALYS HALYS VENOM
Kargin V.D.	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
Karimi M.	-	INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Karimi K.	-	EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
Karimi M.	-	KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D)
	-	FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE
	-	GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	DETERMINATION OF PROTEIN C LEVEL IN NEONATES WITH SEPSIS LIKE ILLNESS
Karlman M.	-	A NEW SIMPLE AND RELIABLE METHOD FOR INVESTIGATING THE AFFINITY BETWEEN COLLAGEN AND VON WILLEBRAND FACTOR IN PLASMA SAMPLES
	-	A NEW SIMPLE AND RELIABLE METHOD FOR INVESTIGATING THE AFFINITY BETWEEN FACTOR VIII AND VON WILLEBRAND FACTOR IN PLASMA SAMPLES
Karlsson A.	-	A NEW SIMPLE AND RELIABLE METHOD FOR INVESTIGATING THE AFFINITY BETWEEN FACTOR VIII AND VON WILLEBRAND FACTOR IN PLASMA SAMPLES
Karlsson L.	-	IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
Karly Hamulyák K.	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
Karniadakis G.E.	-	EFFECT OF PRESENCE OR ABSENCE OF RED CELLS ON EARLY GROWTH RATES OF PLATELET MURAL THROMBI
Karniel E.	-	A NOVEL FUNCTION OF THE PLASMA TRANSGLUTAMINASE - COAGULATION FACTOR XIII: PROTEIN DISULFIDE ISOMERASE (PDI)
Károlyi G.	-	CHAOTIC ADVECTION IN STENOSED ARTERIES
Karoopongse E.	-	THE CORRELATION OF SERUM FERRITIN AND PLATELET ACTIVATION IN BETA-THALASSEMIA MAJOR
Kárpáti L.	-	MOLECULAR MECHANISM OF INTERACTION BETWEEN ACTIVATED FACTOR XIII AND ITS ACYL DONOR PEPTIDE SUBSTRATE
	-	ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
Karpf D.M.	-	CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
Karpf D.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA)
Karpf D.M.	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
Karunakaran D.	-	CONTROL SHEDDING OF GPIB-IX-V AND GPVI BY ADAM FAMILY METALLOPROTEINASES
	-	PROGRAMMED AUTOLOGOUS CLEAVAGE OF PLATELET RECEPTORS
Karyda A.	-	HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL
Kasama E.	-	IDENTIFICATION OF ETS1 AS ASE BINDING PROTEIN: UNIQUE ROLE IN AGE-RELATED GENE REGULATION
Kasanuki H.	-	OPTIMAL ANTICOAGULANT INTENSITY FOR JAPANESE PATIENTS WITH MECHANICAL VALVE
	-	THE RISK FACTORS FOR THROMBOEMBOLISM IN PATIENTS WITH MECHANICAL VALVE
Kasatkina L.	-	HIGH-AFFINITY GLUTAMATE TRANSPORTERS OF BLOOD PLATELETS AS POTENTIAL PERIPHERAL MARKERS TO ANALYZE GLUTAMATE TRANSPORT ACTIVITY IN BRAIN
Kase C.S.	-	ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Kashanian M.	-	EVALUATION OF THE RELATIONSHIP BETWEEN GESTATIONAL DIABETES MELLITUS AND A HISTORY OF POLYCYSTIC OVARIAN SYNDROME
	-	RISK FACTORS IN WOMEN WITH GESTATIONAL DIABETES MELLITUS(GDM)
	-	EVALUATION OF THE HYPERLIPIDEMIA AND HYPERGLYCEMIA IN PROGESTERONE ONLY PILL USERS
Kashif M.	-	FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE
Kashiwagi H.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Kashiwagi T.	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
Kashiwagi A.	-	2-AG PLAY A ROLE ON ASPIRIN RESISTANCE IN TYPE 2 DIABETES
Kashiwakura Y.	-	SILENCING OF A TARGETED PROTEIN IN IN VIVO PLATELETS USING A LENTIVIRAL VECTOR DELIVERING SHORT HAIRPIN RNA SEQUENCE
Kasraian L.	-	TRENDS IN INCIDENCE OF HEPATITIS B AND C IN FARS BLOOD DONORS FROM 2002 TILL END 2006
Kassak P.	-	LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS
Kassim N.	-	THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ?
Kassis J.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Kassouf N.	-	AKT ACTIVATION BY PHOSPHAPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE IN HUMAN PLATELETS IS DEPENDENT ON EXTRACELLULAR CA2+
Kast J.	-	APPLICATION OF PROTEOMICS TO THE IDENTIFICATION OF PROTEINS ASSOCIATED WITH THE PLATELET STORAGE LESION AND THEIR TRANSLATION
Kastally R.	-	SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
Kasthuri R.S.	-	DOES TESTING FOR ANTI BETA-2 GLYCOPROTEIN 1 ANTIBODIES ALTER CLINICAL PRACTICE IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME?
Kastl S.P.	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
	-	THROMBIN UPREGULATES EXPRESSION OF ONCOSTATIN M (OSM) IN HUMAN MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES
	-	IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
Kataoka H.	-	DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
	-	THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
Kato H.	-	CLUSTERING OF SURFACE-BOUND BETA2-GLYCOPROTEIN I
Kato S.	-	IMMUNO-PURIFICATION OF PLASMA ADAMTS13 AND ITS PHYSICO-CHEMICAL CHARACTERIZATION
Kato Y.	-	CLEC-2, A NOVEL PLATELET ACTIVATION RECEPTOR, IS INVOLVED IN PODOPLANIN-MEDIATED PLATELET ACTIVATION BY CANCER CELLS
Kato M.	-	DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
Kato H.	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Kato B.	-	PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
Kato Kaneko M.	-	CLEC-2, A NOVEL PLATELET ACTIVATION RECEPTOR, IS INVOLVED IN PODOPLANIN-MEDIATED PLATELET ACTIVATION BY CANCER CELLS
Katona É.	-	FACTOR XIII VAL34LEU VARIANT PROTECTS AGAINST CORONARY ARTERY DISEASE: A META-ANALYSIS
	-	ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
	-	PRODUCTION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST THE B SUBUNIT OF FACTOR XIII THAT INHIBIT THE FORMATION OF HETEROTETRAMERIC COMPLEX OF A AND B SUBUNITS
Katsadze Y.L.	-	HOMOCYSTEINE LEVELS AND PREVALENCE OF C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN CHILDREN WITH MIGRAINE
Katsaros K.M.	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
	-	IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
	-	THROMBIN UPREGULATES EXPRESSION OF ONCOSTATIN M (OSM) IN HUMAN MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES
Katsarou O.	-	CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
Katsu M.	-	PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
Katsumi A.	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Katsutani S.	-	NOVEL INTERACTING PROTEINS WITH PLATELET 21 CYTOPLASMIC TAILS: RHOGDI AND SLAP-2
Katz B.	-	HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
Katz W.	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Katz B.	-	ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
Kauert G.F.	-	DETERMINATION OF CLOPIDOGREL MAIN METABOLITE IN PLASMA USEFUL TOOL FOR THERAPY MONITORING ?
Kaufman R.J.	-	EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS
	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
Kaufmann V.	-	MEASUREMENT OF THROMBIN GENERATION IN PATIENTS AT RISK FOR ATHEROTHROMBOSIS
	-	MICROPARTICLES IN THROMBIN GENERATION - A SIGNIFICANT PARAMETER INFLUENCING PEAK THROMBIN LEVELS
	-	LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
Kaun C.	-	THROMBIN UPREGULATES EXPRESSION OF ONCOSTATIN M (OSM) IN HUMAN MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES
	-	IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
	-	ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Kaur G.	-	IMPAIRED REGULATION OF PLATELET 12-LIPOXYGENASE (ALOX12) WITH CBFA2/RUNX1 HAPLODEFICIENCY
Kaus L.	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Kauskot A.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
	-	PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
	-	INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
Kavakli K.	-	LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
	-	RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
Kavari M.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Kaveri S.V.	-	IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
	-	COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A
	-	EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
	-	KINETICS OF HYDROLYSIS BY FVIII HYDROLYZING ANTIBODIES IN ACQUIRED HEMOPHILIA A
	-	IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
	-	VWF INHIBITS OF THE ENDOCYTOSIS OF FACTOR VIII BY MURINE BONE MARROW-DERIVED DENDRITIC CELLS
Kawahara T.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Kawahara K.	-	HMGB1 PLAYS A CENTRAL ROLE IN ATHEROTHROMBOSIS
	-	HIGH-MOBILITY GROUP BOX 1 PROTEIN PROMOTES DEVELOPMENT OF MICROVASCULAR THROMBOSIS IN RATS
Kawakami H.	-	LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
Kawamura Y.	-	DISTINCT EFFECTS OF CYCLO-OXYGENASE (COX)-1 INHIBITOR OF ASPIRIN AND P2Y12 INHIBITOR OF CLOPIDOGREL ON THE THREE DIMENSIONAL GROWTH OF ARTERIAL THROMBI FORMED AT SITE OF FUNCTIONAL DAMAGE OF ENDOTHELIAL BY FECL3
Kawano Y.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
	-	REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
Kawao N.	-	EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Kawasaki T.	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Kawasugi K.	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
Kawato M.	-	GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Kay S.	-	ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
Kazazian H.H.	-	SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
Kazemi B.	-	FACTOR V MUTATIONS IN IRANIAN PATIENTS WITH ACTIVATED PROTEIN C RESISTANCE AND VENOUS THROMBOSIS
Kazemi A.	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
Kazimirova M.	-	VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
Keane C.	-	USING A PROTEOMIC APPROACH TO IDENTIFY SPECIFIC STREPTOCOCCAL PROTEINS RESPONSIBLE FOR INDUCING PLATELET AGGREGATION IN INFECTIVE ENDOCARDITIS
Kearney-Schwartz A.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
Kearon C.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
	-	RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Kedem A.	-	HIGH PROPORTION OF MATERNAL THROMBOPHILIA AMONG PREVIOUSLY UNEXPLAINED STILLBIRTH CASES
Kedous A.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Keeling D.M.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
	-	COMPARISON OF AN IMMUNO-TURBIDOMETRIC D-DIMER METHOD WITH AN ESTABLISHED ENZYME-LINKED FLUORESCENT D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLISM
Keenan C.	-	HIGH RISK FOR VENOUS THROMBOEMBOLISM IN DIABETICS WITH HYPEROSMOLAR STATE: COMPARISON WITH OTHER ACUTE MEDICAL ILLNESSES
Keeney S.	-	DETECTION OF PARTIAL F8 GENE DELETIONS IN HAEMOPHILIA A CARRIER DIAGNOSIS
Keeney M.	-	USE OF A HUMAN-DERIVED D-DIMER PREPARATION IN EXTERNAL QUALITY ASSESSMENT (EQA)
Kehrel B.E.	-	ACTIVATED PLATELETS ENHANCE THE ADHERENCE TO AND INVASION OF ENDOTHELIAL CELLS BY STAPHYLOCOCCUS AUREUS
	-	THROMBOSPONDIN-1 INHIBITS PLATELET AND MONOCYTE ACTIVATION BY HOCL-OXIDISED PROTEINS
Keightley A.M.	-	INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Keijzer M.	-	B-VITAMIN SUPPLEMENTATION LOWERS PLASMA HOMOCYSTEINE CONCENTRATION BUT DOES NOT AFFECT PLASMA METHIONINE AND CYSTEINE CONCENTRATIONS: A POSSIBLE EXPLANATION FOR NEGATIVE RESULTS OF CLINICAL TRIALS
Keil B.	-	THE EFFECT OF APCC AND PCC ON THE GENERATION OF THROMBIN IN HAEMOPHILIA A PATIENTS WITH FVIII INHIBITOR: A CROSS-OVER PHARMACOKINETIC STUDY
Kelahar N.	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
Kelderman M.	-	IDENTIFICATION OF TYPE 2M VON WILLEBRAND DISEASE BY DENSITOMETRIC ANALYSIS OF VON WILLEBRAND FACTOR MULTIMER PATTERNS
Kelleher K.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Kellenberger C.	-	PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY
Keller T.T.	-	ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL
Keller L.	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
	-	VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
	-	TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC
	-	AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Kelly M.E.	-	EFFICIENT INDUCTION OF IMMUNE TOLERANCE TO FIX FOLLOWING DIRECT INTRAMUSCULAR GENE TRANSFER
	-	INDUCTION OF FIX TOLERANCE BY DIRECT INTRAMUSCULAR INJECTION OF AAV IS AAV-DOSE/FIX-LEVEL DEPENDENT
	-	TOLERANCE INDUCTION TO FIX IN MICE WITH PRE-EXISTING ANTI-FIX IMMUNITY FOLLOWING DIRECT INTRAMUSCULAR INJECTION OF AAV
Kelton J.G.	-	FACTORS INFLUENCING THE ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODY (ANTI-PF4/H AB) IMMUNE RESPONSE: AN ANALYSIS OF FOUR RANDOMIZED CONTROLLED TRIALS (RCT'S) COMPARING ENOXAPARIN (ENOX) TO FONDAPARINUX (FONDA)
Kemball-Cook G.	-	3D STRUCTURES OF MEMBRANE-BOUND FACTOR VIII
	-	A CRYO-ELECTRON MICROSCOPY STUDY OF RECOMBINANT FVIII BINDING TO PS LIPOSOMES
Kemeny G.	-	STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
Kemkes-Matthes B.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	THROMBOPHILIA AND SPONTANEOUS ABORTION THERAPY WITH LMW-HEPARI
	-	GIESSEN THROMBOPHILIA STUDY: MANIFESTATION AGE OF THROMBOEMBOLISM IN THROMBOPHILIA
Kemp D.M.	-	INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASES IMPAIRS ADIPOSE TISSUE DEVELOPMENT IN MOUSE MODELS OF OBESITY
Kempf G.	-	COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING
Kempfer A.C.	-	BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
	-	TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC
Kempfer A.	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
	-	VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
Kempfer A.C.	-	EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
Kempfer A.	-	IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
	-	AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Kempfer A.C.	-	ANTITHROMBIN (AT): A CONFORMATIONAL VARIANT?
Kempton C.L.	-	HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
Kenet G.	-	THE FACTOR II G20210A VARIANT, POOR PATENCY RATES, AND OLDER AGE AT ONSET ARE INDEPENDENT RISK FACTORS FOR RECURRENT VENOUS THROMBOEMBOLISM
	-	PAEDIATRIC STROKE
	-	PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA
	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
	-	CAN THROMBIN GENERATION (TG) BE USED TO MONITOR RFVIIA TREATMENT: IN VIVO "MINI-PK" STUDY IN HEMOPHILIA A PATIENTS
	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
	-	A RECOMBINANT FACTOR VIIA ANALOGUE WITH ENHANCED POTENCY, EXPRESSED BY THROMBIN GENERATION, AND PHOSPHOLIPIDS DEPENDENCY: AN IN VITRO STUDY
Kennebäck G.	-	ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE
Kennedy M.	-	ARGATROBAN DOSE REQUIREMENTS IN INTENSIVE CARE UNIT PATIENTS
	-	AN EVALUATION OF AN ARGATROBAN DOSE TITRATION NOMOGRAM
Kennedy A.	-	PR-15 A NOVEL INTRAVENOUS INHIBITOR OF PLATELET ADHESION: A PHASE I DOSE ASCENDING PHARMACOKINETIC, PHARMACODYNAMIC, AND TOLERANCE STUDY
Kenny D.	-	A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION
	-	S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
Keown M.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
	-	LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
	-	QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA
	-	A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS
	-	EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
Kerachian M.	-	PROCOAGULANT EFFECT OF DEXAMETHASONE IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS: A POTENTIAL MECHANISM OF GLUCOCORTICOID-INDUCED OSTEONECROSIS
Kerbiriou-Nabias D.M.	-	THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Kere J.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Kerecsen G.	-	STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
	-	ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS
Kergenskova J.G.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Kerkau T.	-	AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
Kerleau J.M.	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
Kermode J.C.	-	CONTRIBUTION OF INDIVIDUAL PURINOCEPTOR SUBTYPES TO PLATELET ACTIVATION BY VON WILLEBRAND FACTOR UNDER STATIC CONDITIONS
	-	CHARACTERIZATION OF A NEW METHOD TO ASSESS PLATELET ACTIVATION AND ERYTHROCYTE LYSIS DURING EXPOSURE TO PATHOPHYSIOLOGICAL SHEAR STRESS
Kern L.	-	THE DIFFERENCES OF PLATELET RESPONSE TO SNAKE VENOMS: COMPARATIVE STUDY OF CHILDREN AND ADULTS
Kerr R.	-	COAGULATION STUDIES IN PATIENTS PRESENTING WITH HYPOTHERMIA
Kerr-Conte J.	-	ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION
Kerrigan S.W.	-	A NOVEL GPIB ALPHA BINDING PROTEIN ON STREPTOCOCCUS GORDONII INDUCES PLATELET ROLLING AT LOW SHEAR
	-	USING A PROTEOMIC APPROACH TO IDENTIFY SPECIFIC STREPTOCOCCAL PROTEINS RESPONSIBLE FOR INDUCING PLATELET AGGREGATION IN INFECTIVE ENDOCARDITIS
Kerrigan S.	-	STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
Kerrigan S.W.	-	A DYNAMIC MODEL OF THE BLOOD-BRAIN BARRIER
Kerschen E.J.	-	MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
	-	FIBRIN A-ALPHA PEPTIDE MEDIATED DELIVERY OF BIOLOGICALLY ACTIVE PROTEINS
Kessel C.	-	RESPONSE TO RITUXIMAB AND EPITOPE MAPPING OF INHIBITORY ANTIBODIES IN ACQUIRED HAEMOPHILIA
	-	POTENTIAL USE OF LIGANDS TO FVIII INHIBITORS
	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
Kessler P.	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Kessler C.M.	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Kessler T.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Kessler C.M.	-	EFFICACY OF A FVIII/VWF CONCENTRATE AS REPLACEMENT THERAPY IN PREVENTING EXCESSIVE BLEEDING IN SUBJECTS WITH CONGENITAL VON WILLEBRAND DISEASE (VWD) WHO UNDERWENT SURGICAL OR INVASIVE PROCEDURES
Kesteven P.	-	WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
Ketteler M.	-	Circulating inactive human Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular disease
Keuren J.J.F.W.	-	FACTOR VA BOUND TO STORAGE INDUCED MICROPARTICLES HAVE REDUCED APC CATALYZED INACTIVATION
Key N.S.	-	STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
Keyes T.E.	-	S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
Kgami S.	-	REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
Khair K.	-	PLATELET FUNCTION TESTING IN CHILDREN UNDER 1 YEAR
Khametova R.N.	-	EFFICACY AND SAFETY OF FVIII WITH PEGYLATED LIPOSOMES IN HAEMOPHILIA A
Khan N.	-	USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
Khan M.M.	-	CLEAVED HIGH MOLECULAR WEIGHT KININOGEN (HKA) STIMULATES EXPRESSION OF MONOCYTE TISSUE FACTOR (TF) DEPENDENT ON SECRETION OF CYTOKINES AND CHEMOKINES
Khan A.	-	EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Khandoga A.L.	-	THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
Khanin M.A.	-	STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
	-	STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
	-	MECHANISM OF BLOOD COAGULATION TRIGGERING: A MATHEMATICAL MODEL
	-	CLOT FORMATION AS TREATMENT METHOD FOR PATHOLOGICAL FOCUS: A MATHEMATICAL MODEL
	-	STUDY OF RECOMBINANT FACTOR VIIA ACTION MECHANISM: A MATHEMATICAL MODEL
Khashoggi T.Y.	-	HAEMOSTATIC AND CYTOKINE CHANGES IN GESTATIONAL AND PREGESTATIONAL DIABETES MELLITUS
Khaspekova S.G.	-	VARIATIONS OF PLATELET GLYCOPROTEIN IIB-IIIA QUANTITY AFFECTS PLATELET AGGREGATION AND SENSITIVITY TO GLYCOPROTEIN IIB-IIIA ANTAGONISTS
Khattak H.	-	CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH PLASMA MARKERS OF PRO-ATHEROGENIC PROCESSES IN RHEUMATOID ARTHRITIS
Khau van Kien P.	-	INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
Khau Van Kien A.	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
	-	SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
Khayat G.R.	-	ASSESSMENT OF ACTIONS FOR IMPROVING PREVENTION OF THROMBOEMBOLIC DISEASE IN MEDICAL PATIENTS
Khayat C.	-	ASSESSMENT OF ACTIONS FOR IMPROVING PREVENTION OF THROMBOEMBOLIC DISEASE IN MEDICAL PATIENTS
Kheirandish M.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Khludneva I.D.	-	CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
Khokhlov N.V.	-	EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
	-	SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
Khorana A.A.	-	INCREASING RATE OF VENOUS THROMBOEMBOLISM AMONG HOSPITALIZED CANCER PATIENTS
	-	DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR CHEMOTHERAPY-ASSOCIATED THROMBOSIS
Khoury G.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Khromov I.S.	-	SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
	-	EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
Khuri S.F.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Kienitz C.	-	EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
Kiernan A.	-	SUB-CELLULAR LOCALIZATION REGULATES THE INTERACTION BETWEEN THE PLATELET INTEGRIN IIB3 AND ICLN
	-	A ROLE FOR ADIPONENCTIN IN HUMAN PLATELET FUNCTION?
Kierulf P.	-	FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
Kierzek G.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
Kiesewetter H.	-	EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII (NOVOSEVEN) IN TRAUMA AND SURGERY PATIENTS WITH MASSIVE BLEEDING A REGISTER ANALYSIS
Kile B.T.	-	PROGRAMMED ANUCLEAR CELL DEATH DELIMITS PLATELET LIFE SPAN
Killeen A.A.	-	DOES TESTING FOR ANTI BETA-2 GLYCOPROTEIN 1 ANTIBODIES ALTER CLINICAL PRACTICE IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME?
Kim S.	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Kim M.	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Kim H.	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Kim M.	-	THROMBOPHILIC POLYMORPHISMS IN PEDIATRIC CATHETER RELATED VERSUS NON CATHETER RELATED VENOUS THROMBOEMBOLISM
Kim T.	-	ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
	-	ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
Kim A.Y.	-	RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Kim D.	-	DISINTEGRIN SUPPRESSES HUMAN VASCULAR ENDOTHELIAL CELL MIGRATION AND INVASION BY REGULATING PLATELET ACTIVATION
	-	DISINTEGRIN SUPPRESSES HUMAN VASCULAR ENDOTHELIAL CELL MIGRATION AND INVASION BY REGULATING PLATELET ACTIVATION
Kim T.	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Kim D.	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Kim T.	-	EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Kim D.	-	EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Kim H.	-	MONITORING OF PLATELET FUNCTION AFTER CLOPIDOGREL TREATMENT
Kim J.	-	ANTITHROMBIC EFFECT OF DJW ON PLATELET-ACTIVATING FACTOR-INDUCED PLATELET AGGREGATION
Kim S.	-	ROLE OF PI-3 KINASE BETA ISOFORM ON ADP-INDUCED PLATELET RESPONSES
Kim H.C.	-	LIVING DONOR LIVER TRANSPLANTATION FOR HBV-ASSOCIATED HEPATOMA IN A HEMOPHILIC PATIENT
Kim M.	-	KNOWLEDGE AND BEHAVIORS REGARDING COMPLICATION AND PREVENTION OF PATIENTS WITH HEMOPHILA IN KOREA
	-	PREVALENCE OF HEPATITIS B AND C AND ABNORMAL LIVER FUNCTION TESTS IN PATIENTS WITH HEMOPHILIA IN KOREA
Kim P.Y.	-	CHARACTERIZATION OF A PENTAPEPTIDE THAT MODULATES PROTHROMBINASE ACTIVITY
	-	THE INTERACTION OF PROTHROMBIN WITH THE MEMBRANE SURFACE IS A PREREQUISITE FOR OPTIMUM EXPRESSION OF FACTOR VA COFACTOR ACTIVITY WITHIN PROTHROMBINASE
Kim K.	-	COMPARISON OF LABORATORY DETECTION METHODS OF ASPIRIN RESISTANCE IN CARDIOVASCULAR DISEASE PATIENTS
Kim P.Y.	-	FURTHER EVIDENCE FOR TWO FUNCTIONAL FORMS OF PROTHROMBINASE
Kim M.	-	COMPARISON OF LABORATORY DETECTION METHODS OF ASPIRIN RESISTANCE IN CARDIOVASCULAR DISEASE PATIENTS
Kim P.Y.	-	A NEW FUNCTIONAL ASSAY FOR MEASURING PLASMA TAFIA AND ITS USE TO DEMONSTRATE TAFI ACTIVATION IN VIVO IN A PRIMATE MODEL
Kim T.	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
	-	EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
	-	CERAMIDE KINASE/CERAMIDE 1-PHOSPHATE IS AN IMPORTANT REGULATOR ON AORTIC VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
Kim A.Y.	-	EFFICACY OF WHOLE BLOOD PLATELET AGGREGATION IN THE EVALUATION OF BLEEDING OR THROMBOTIC TENDENCIES
Kim A.	-	VARIATIONS IN PLATELET FUNCTION TEST OF NORMAL INDIVIDUALS MAY AFFECT TEST INTERPRETATIONS
Kim D.	-	ANTITHROMBOTIC EFFECT OF RECOMBINANT DISINTEGRIN IN A MOUSE THROMBOSIS MODEL
Kim T.	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Kim I.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Kim J.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Kim N.	-	C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
Kim O.	-	C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
Kim H.	-	C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
Kim N.	-	GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Kim O.	-	GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Kim H.	-	PLASMA LEVEL OF STROMAL DERIVED FACTOR-1 (SDF-1) IS INCREASED IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WHO HAVE A POOR OUTCOME: IN VITRO EFFECT OF SDF-1 ON COAGULOPATHY
Kim J.	-	PLASMA LEVEL OF STROMAL DERIVED FACTOR-1 (SDF-1) IS INCREASED IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WHO HAVE A POOR OUTCOME: IN VITRO EFFECT OF SDF-1 ON COAGULOPATHY
Kim S.	-	REGULATION OF INSULIN-LIKE GROWTH FACTOR 1 IN PLATELET ACTIVATION
	-	RHOA/P160ROCK PLAYS AN IMPORTANT ROLE IN THE DENSE GRANULE RELEASE OF PLATELETS
Kim J.	-	INTRACRANIAL HEMORRHAGE IN AN ACUTE ITP PATIENT WITH MODERATE THROMBOCYTOPENIA
Kim J.Y.	-	INTERMEDIATE-DOSE PROPHYLAXIS EXPERIENCE FOR KOREAN HEMOPHILIA PATIENTS
Kim N.	-	PROGNOSTIC SIGNIFICANCE OF THE POLYMORPHISMS IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR C677T) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) GENE IN EPILEPSY
Kim O.	-	PROGNOSTIC SIGNIFICANCE OF THE POLYMORPHISMS IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR C677T) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) GENE IN EPILEPSY
Kim N.	-	ANALYSIS OF EFFECTS OF METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) POLYMORPHISMS ON HOMOCYSTEINE CONCENTRATION AND RECURRENT SPONTANEOUS ABORTION IN KOREANS
Kim S.	-	ZEBRAFISH: FROM HEMATOLOGY TO HYDROLOGY
Kimbimbi P.	-	USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
Kimmel-Jehan C.	-	CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING
	-	EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
Kimmet A.	-	HANDHELD COMPUTERS: AN EFFECTIVE SYSTEM TO RECORD HOME-THERAPY DATA OF PATIENTS WITH HAEMOPHILIA
Kimura R.	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Kimura Y.	-	A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY
Kimura H.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Kimura Y.	-	EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Kinealy K.	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
Kinev A.V.	-	THE TRANSCRIPTION FACTOR EGR-1 PLAYS A CRITICAL ROLE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS
King S.M.	-	PLATELET DENSE GRANULE SECRETION ACCELERATES THE DEVELOPMENT OF ARTERIOSCLEROSIS AFTER VASCULAR INJURY
King L.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
King J.	-	SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
King J.H.	-	LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
King V.	-	APPLICABILITY OF A THROMBIN GENERATION TEST IN LABORATORY SCREENING
King J.	-	EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
	-	IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
Kini R.M.	-	VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
	-	STRUCTURE AND REGULATION OF A VENOM PROTHROMBIN ACTIVATOR GENE IN TROPIDECHIS CARINATUS SNAKE: A UNIQUE CIS-REGULATORY REGION RESPONSIBLE FOR THE ELEVATED EXPRESSION IN THE VENOM GLAND
Kirby A.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Kirchmaier C.	-	THROMBIN-INDUCED INTERLEUKIN 1BETA SYNTHESIS IN PLATELET SUSPENSIONS: IMPACT OF CONTAMINATING LEUKOCYTES
Kirchmaier C.M.	-	TESTING FVIIA EFFICACY AS A POTENTIAL TREATMENT FOR PATIENTS WITH HERMANSKY-PUDLAK-SYNDROME TYPE 1 (HPS-1) WITH A THROMBIN GENERATION TEST (TGT) IN TWO CASES
Kirchmaier C.	-	EFFECT OF RFVIIA (NOVOSEVEN,) AND FEIBA (FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY) ON ANTICOAGULANT-INDUCED INHIBITION OF THROMBIN GENERATION IN PLATELET-RICH PLASMA (PRP)
	-	RESPONSE TO RITUXIMAB AND EPITOPE MAPPING OF INHIBITORY ANTIBODIES IN ACQUIRED HAEMOPHILIA
	-	INFLUENCE OF ANTIEPILEPTIC DRUGS ON THE COAGULATION
Kireev D.A.	-	THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR
Kirkham F.J.	-	PAEDIATRIC STROKE
	-	THE FACTOR II G20210A VARIANT, POOR PATENCY RATES, AND OLDER AGE AT ONSET ARE INDEPENDENT RISK FACTORS FOR RECURRENT VENOUS THROMBOEMBOLISM
Kirsch M.	-	A NEW ANTITHROMBOTIC STRATEGY FOR PATIENTS WITH LONG TERM MECHANICAL CIRCULATORY SUPPORT (MCS)
Kirton A.	-	OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS
	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Kis A.	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
Kishikawa M.	-	PHYTOESTROGENS DOWN-REGULATE PROTEIN S EXPRESSION IN HEPG2 CELLS
Kishiwada M.	-	REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
Kisiel W.	-	IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
	-	EXPRESSION OF TISSUE FACTOR (TF), FACTOR X, PROTHROMBIN FRAGMENT 1+2 (F 1+2) AND FIBRIN IN BREAST CANCER: COMPARISON BETWEEN PRIMARY TUMOR AND METASTATIC LESIONS IN REGIONAL LYMPH NODES
Kiss N.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Kiss R.G.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Kiss R.	-	ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS
Kiss N.	-	ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS
Kiss A.	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Kiss N.	-	STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
Kiss R.G.	-	STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
	-	CLOPIDOGREL TREATMENT SIGNIFICANTLY DECREASES CIRCULATING ENDOTHELIAL CELL COUNT IN PATIENTS WITH STABLE ANGINA
Kiss F.	-	ANALYSIS OF SURFACE AND SOLUBLE L-SELECTIN IN RELATION TO FLOW CYTOMETRIC PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Kisucka J.	-	PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
	-	PEROXIREDOXIN, PRDX1 PLAYS AN IMPORTANT ROLE IN INFLAMMATION AND EARLY ATHEROSCLEROSIS
	-	CHARACTERIZATION OF THE ROLE OF PLATELET ADHESION MOLECULES IN A MURINE MODEL OF PHOTOSENSITIZER-INDUCED STROKE
Kita T.	-	GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Kitada Y.	-	PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
	-	THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
Kitajima I.	-	THE RELATIONSHIP BETWEEN STRANDING IN CARS AND DVT AFTER THE MIDDLE NIIGATA PREFECTURE EARTHQUAKE 2004
	-	CONTRIBUTION OF FACTOR XA (FXA) IN THE THREE DIMENSIONAL GROWTH OF PLATELET THROMBI FORMED ON COLLAGEN FIBRILS UNDER BLOOD FLOW CONDITIONS
Kitamura K.	-	MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Kitamura S.	-	EFFECTS OF E5555, A PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONIST, ON THE INFLAMMATORY MARKERS IN VITRO
Kitanovski L.	-	INHIBITOR DEVELOPMENT IN 3 PATIENTS WITH HEMOPHILIA A AFTER INTENSIVE EXPOSURE TO FVIII CONCENTRATES BY CONTINUOUS INFUSION DATA FROM SLOVENIA
Kitchen S.	-	IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY
	-	SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS
Kitchen V.S.	-	ELTROMBOPAG, THE ORAL PLATELET GROWTH FACTOR, INCREASED PLATELET COUNT AND DID NOT AFFECT PLATELET FUNCTION WHEN ADMINISTERED TO HEALTHY MALE SUBJECTS
Kitchen D.P.	-	SOURCE AND USE OF REFERENCE RANGES IN HAEMOSTASIS: PRACTICE AMONGST UK NEQAS FOR BLOOD COAGULATION PARTICIPANTS 2005-6
Kitchen S.	-	SOURCE AND USE OF REFERENCE RANGES IN HAEMOSTASIS: PRACTICE AMONGST UK NEQAS FOR BLOOD COAGULATION PARTICIPANTS 2005-6
Kitchen D.P.	-	AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR PATIENT SELF-TESTING FOR MONITORING INRS- 2 YEARS OF RESULTS
Kitchen S.	-	AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR PATIENT SELF-TESTING FOR MONITORING INRS- 2 YEARS OF RESULTS
Kitchen D.P.	-	IMPLEMENTING AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR USERS OF COAGUCHEK XS AND COAGUCHEK XS PLUS FOR MONITORING INRS
Kitchen S.	-	IMPLEMENTING AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR USERS OF COAGUCHEK XS AND COAGUCHEK XS PLUS FOR MONITORING INRS
	-	SENSITIVITY OF THE HEMOSIL THROMBOPATH ASSAY TO DEFECTS IN THE PROTEIN C ANTICOAGULANT PATHWAY
Kitchen D.P.	-	VARIABILITY IN ANTICOAGULANT DOSING RECOMMENDATIONS; RESULTS FROM TWO UK NEQAS FOR BLOOD COAGULATION EXERCISES
Kitchen S.	-	VARIABILITY IN ANTICOAGULANT DOSING RECOMMENDATIONS; RESULTS FROM TWO UK NEQAS FOR BLOOD COAGULATION EXERCISES
	-	FACTOR VIII ASSAY DISCREPANCY IN TYPE 2N VWD IS REAGENT DEPENDANT
	-	THE CHROMOGENIC FVIII:C ASSAY IS A SUITABLE ALTERNATIVE TO THE TWO-STAGE ASSAY IN DETECTION OF MILD HAEMOPHILIA A PATIENTS WITH ONE-STAGE, TWO-STAGE DISCREPANCY
	-	THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (UK NEQAS) FOR MOLECULAR GENETIC TESTING IN HAEMOPHILIA
	-	ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
	-	EVALUATION OF A NEW LATEX-BASED HOMOCYSTEINE ASSAY
	-	COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT)
	-	COMPARISON OF THROMBIN GENERATION WITH MODIFIED THROMBOELASTOMETRY IN HAEMOPHILIA A
	-	THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES: MARKED DIFFERENCES IN FV AND FXI RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS
Kitchen D.P.	-	THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES: MARKED DIFFERENCES IN FV AND FXI RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS
Kitchen S.	-	THROMBIN GENERATION TO MONITOR INHIBITOR BYPASS AGENTS REQUIRES LOW CONCENTRATIONS OF TISSUE FACTOR (TF)
	-	DIFFERENCES IN THROMBOPHILIA ASSAY RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS USING THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES
Kitchen D.P.	-	DIFFERENCES IN THROMBOPHILIA ASSAY RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS USING THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES
Kito F.	-	EFFECT OF A FACTOR XA INHIBITOR DU-176B ON INTRACEREBRAL HEMORRHAGE IN RATS: A WIDER SAFETY MARGIN COMPARED WITH A THROMBIN INHIBITOR
	-	EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
Kitpoka P.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
Kitzmueller E.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Kjalke M.	-	COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS
	-	EFFECT OF FACTOR XIII ON THE ANTI-FIBRINOLYTIC ACTIVITY OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI)
	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
	-	FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Kjelgaard-Hansen M.	-	PROSPECTIVE DESIGN OF A NEW, OBJECTIVE SCORING SYSTEM FOR IDENTIFYING DISSEMINATED INTRAVASCULAR COAGULATION IN DOGS A SPONTANEOUS ANIMAL MODEL
Klaeffling C.	-	ALTERNATIVE ANTICOAGULATION WITH DANAPAROID IN TWO PREGNANCIES IN A PATIENT WITH FORMER HIT, THROMBOPHILIA, A HISTORY OF VENOUS THROMBOSIS AND RECURRENT PREGNANCY LOSSES
Klamroth R.	-	PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
	-	LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA
	-	INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
	-	SECOND INTERIM ANALYSIS OF A LONG-TERM PHARMACOVIGILANCE PROJECT WITH A PLASMA DERIVED FVIII CONCENTRATE
	-	10-YEARS EFFICACY, SAFETY AND INHIBITORS IN ONE PLASMA-DERIVED FACTOR VIII CONCENTRATE
	-	SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION OF RECURRENT ELBOW JOINT BLEEDS IN FIVE PATIENT WITH SEVERE HAEMOPHILIA A
	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
Klank D.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Klauss V.	-	MONITORING OF ANTIPLATELET THERAPY BEFORE AND AFTER SURGICAL PROCEDURES IN PATIENTS WITH CORONARY STENTS
Klein A.K.	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Kleinschnitz C.	-	INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
Kleinstück B.B.K.	-	RESULTS OF A ONE-YEAR REGISTRY OF BLEEDING COMPLICATIONS OF VITAMIN K ANTAGONIST THERAPY OUTSIDE A CONTROLLED POPULATION
Kleitz L.	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
Klement G.L.	-	PLATELET-FACILITATED DELIVERY OF ANGIOGENESIS REGLULATORS IS CONTROLLED BY TISSUE PROTEASES
Klement P.	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
Klempnauer J.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Klenkova N.A.	-	THE ROLE OF DNA POLYMORPHISMS IN GENES CODING THE HOMOCYSTEINE AND FOLATE METABOLIZING ENZYMES IN ISCHAEMIC HEART DISEASE
	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
Klersy C.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Klich K.	-	POTENTIAL USE OF LIGANDS TO FVIII INHIBITORS
	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
Klil A.	-	COAGULATION PARAMETERS IN AMNIOTIC FLUID DURING HUMAN PREGNANCY ROLE OF TF AND TFPI
Klimavicute A.	-	DALTEPARIN SHORTENS HUMAN LABOR
Klimovich L.G.	-	USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
	-	CLOTTING AND INFLAMMATION MARKERS WHEN INCLUDING RECOMBINANT ACTIVATED PROTEIN C (RAPC) IN SEPSIS THERAPY
Kline J.A.	-	MATRIX METALLOPROTEIN-9 IS ELEVATED IN BLOOD FROM PATIENTS WITH PULMONARY EMBOLISM AND RIGHT VENTRICULAR HYPOKINESIS ON ECHOCARDIOGRAPHY
	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
	-	DECLINING RATE OF VENOUS THROMBOEMBOLISM IN PATIENTS EVALUATED FOR PULMONARY EMBOLISM IN TWO UNITED STATES EMERGENCY DEPARTMENTS AND LOW RATE OF EMPIRIC ANTICOAGULATION
	-	EVALUATION OF 50 POTENTIAL MARKERS OF PULMONARY EMBOLISM FOR USE IN THE EMERGENCY DEPARTMENT
	-	TANDEM MEASUREMENT OF D DIMER AND MYELOPEROXIDASE DECREASES UNNECESSARY PULMONARY VASCULAR IMAGING IN EMERGENCY DEPARTMENT PATIENTS EVALUATED FOR PULMONARY EMBOLISM
Klingebiel T.	-	EXPERIENCES IN THERAPY AND OUTCOME OF ADOLESCENTS WITH ACUTE VENOUS THROMBOSIS
Klingenberg O.	-	FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
Klinkhardt U.	-	FRACTALKINE RECEPTOR CX3CR1 EXPRESSION IN PLATELETS FROM PATIENTS WITH CARDIOVASCULAR DISEASE
Klöckner S.	-	INTERACTION BETWEEN ORAL CONTRACEPTIVE USE AND COAGULATION FACTOR LEVELS IN DEEP VEIN THROMBOSIS
Klok F.A.	-	COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
	-	RISK FACTORS FOR MORTALITY THREE MONTHS AFTER PULMONARY EMBOLISM
	-	FACTOR V LEIDEN IS ASSOCIATED WITH MORE DISTAL LOCATION OF DEEP VEIN THROMBOSIS OF THE LEG
	-	PULMONARY EMBOLISM FAILURE RATE IN PATIENTS IN WHOM PULMONARY EMBOLISM WAS RULED OUT BY LOW AND INTERMEDIATE PROBABILITY BY THE REVISED GENEVA SCORE AND A NORMAL QUANTITATIVE D-DIMER TEST RESULT
Kloos M.	-	RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD
Kluft C.	-	THE USE OF THE ENDOGENOUS THROMBIN POTENTIAL ASSAY IN THE DIAGNOSIS OF DEEP VENOUS THROMBOSIS
	-	THE THROMBIN GENERATION TEST NEEDS TO BE SUPPLEMENTED WITH ADDITIONAL TESTS TO FULLY DOCUMENT THE EFFECTS OF THROMBIN INHIBITORS: EVALUATION FOR MELAGATRAN
	-	LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
	-	INTER-LABORATORY VARIATION AND THE EFFECT OF THE TYPE OF FLUORIMETER ON THE RESULTS OF THE TECHNOTHROMBIN THROMBIN GENERATION ASSAY
	-	EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
	-	QUANTIFICATION OF THE MEASUREMENT UNCERTAINTY FOR D-DIMER ASSAY RESULTS AROUND THE CUT-OFF LEVEL: IMPROVED DECISION RULES REQUIRED?
	-	A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS
	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
	-	QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA
Kluijtmans L.A.J.	-	SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE
Klukowska A.	-	EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
	-	LOW INCIDENCE OF INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS WITH HAEMOPHILIA A
	-	EVALUATION OF EFFICACY OF RADIOACTIVE SYNOVECTOMY IN RECURRENT JOINT BLEEDING IN HAEMOPHILIA
	-	HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR
	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
	-	ABSENCE OF INHIBITOR FORMATION IN PREVIOUSLY TREATED HAEMOPHILIA A PATIENTS TREATED WITH A DOUBLE VIRUS INACTIVATED, PLASMA DERIVED FACTOR VIII/VWF CONCENTRATE IN PROSPECTIVE CLINICAL STUDIES
Klüter H.	-	DOPAMINE IS A COACTIVATOR FOR PLATELET ADHESION TO COLLAGEN AND ACTS VIA D2-LIKE RECEPTORS
	-	THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
Knabb R.M.	-	POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
	-	INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
Knapp-Clevenger R.	-	A THROMBOLYTIC REGIMEN FOR HIGH-RISK DEEP VENOUS THROMBOSIS MAY SUBSTANTIALLY REDUCE THE RISK OF POST-THROMBOTIC SYNDROME IN CHILDREN
Knappe S.	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
	-	AV513 ENHANCES TISSUE FACTOR ACTIVITY AND STIMULATES THROMBIN GENERATION IN HEMOPHILIA A PLASMA
Knaub S.	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
	-	PHARMACOKINETICS OF A PROTHROMBIN COMPLEX CONCENTRATE IN HEALTHY VOLUNTEERS
	-	SECOND INTERIM ANALYSIS OF A LONG-TERM PHARMACOVIGILANCE PROJECT WITH A PLASMA DERIVED FVIII CONCENTRATE
	-	LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Knight S.	-	AUDIT OF SCREENING FOR VON WILLEBRANDS DISEASE AND PLATELET FUNCTION ABNORMALITIES USING THE PFA-100
Knight G.	-	THE EFFECT OF THE SUGARBAKER PROCEDURE ON HAEMOSTASIS
Knobe K.E.	-	FEMALE HEMOPHILIA A - TWO UNUSUAL CASES DUE TO SKEWED X-INACTIVATION
	-	STUDIES OF mRNA IN PATIENTS WITH UNDETECTABLE MUTATIONS IN GENOMIC DNA
Knöbl P.	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Knoebl P.N.	-	FUNCTIONAL COAGULATION ANALYSIS IN PATIENTS WITH BLOOD COAGULATION DISORDERS OR HYPERCOAGULABILITY: SIGNIFICANCE OF WHOLE BLOOD ROTATION THROMBELASTOGRAPHY IN COMPARISON WITH CONVENTIONAL BLOOD COAGULATION ANALYSIS
	-	SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
Knoefler R.	-	INFLUENCE OF DESMOPRESSIN ON HEMOSTASIS IN CHILDREN WITH BLEEDING DISORDERS
Knoester H.	-	VENOUS THROMBOSIS AND THE POST THROMBOTIC SYNDROME AFTER FEMORAL CATHETERIZATION
Knöfler R.	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
	-	VARIABILITY IN PERFORMING PLATELET AGGREGOMETRY FOR DIAGNOSIS OF INBORN DISORDERS OF PLATELET FUNCTION IN GERMANY, AUSTRIA AND SWITZERLAND
Knoppert D.C.	-	DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
Knuchel N.	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
Ko R.	-	COMPARISON OF LABORATORY DETECTION METHODS OF ASPIRIN RESISTANCE IN CARDIOVASCULAR DISEASE PATIENTS
Kobayashi E.	-	INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Kobayashi K.	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
Kobayashi T.	-	ADAMTS13 RELATED MARKERS IN PLASMA FROM PATIENTS WITH TTP
	-	ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
Kobayashi E.	-	CHARACTERISTIC FEATURES OF SOLUBLE FIBRIN (SF) AND SOLUBLE FIBRIN MONOMER COMPLEX (FMC) AS MEASURED BY IMMUNOASSAYS WITH IATRO SF AND AUTO LIAFM, RESPECTIVELY
Kobiljanskaja V.A.	-	LUPUS ANTICOAGULANT: LABORATORY DIAGNOSIS FROM PATIENTS WITH THROMBOSIS
Kobilyanskaya V.A.	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
Kobzdej M.M.	-	PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC
Koceva S.	-	A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT)
Koch A.	-	PERCUTANEOUS CATHETER EXTRACTION OF A RUPTURED PORT-A-CATH IN A SMALL CHILD WITH HAEMOPHILIA A AND F VIII INHIBITOR USING CONTINUOUS INFUSION OF RFVIIA
Koch K.	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
	-	SUCCESSFUL OUTCOME OF THE WTCCC GENOME-WIDE ASSOCIATION STUDY SHOWS THAT BLOOD DONORS REFLECT THE UK POPULATION STRUCTURE AND CAN BE USED AS COMMON CONTROLS
Koder S.	-	SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY
	-	PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE)
	-	P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
	-	SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
Koehler A.	-	PHARMACOKINETICS OF DIPETARUDIN AND PEG-DIPETARUDIN IN PIGS
Koehler-Vajta K.E.	-	ANTIVIRAL TREATMENT OF HCV INFECTED YOUNG HAEMOPHILIACS AN UPDATE OF 14 YEARS EXPERIENCE IN A PRIVATE PRACTICE CCC
Koekman A.	-	LDL-INDUCED PLATELET ACTIVATION INVOLVES SPECIFIC DOMAINS IN APOB100
Koene H.R.	-	JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM
Koenig C.	-	PLATELET PROINFLAMMATORY AND HEMOSTATIC FUNCTIONS IN PATIENTS WITH CYSTIC FIBROSIS
Koenigs C.	-	RESPONSE TO RITUXIMAB AND EPITOPE MAPPING OF INHIBITORY ANTIBODIES IN ACQUIRED HAEMOPHILIA
Koerber J.M.	-	AN EVALUATION OF AN ARGATROBAN DOSE TITRATION NOMOGRAM
	-	ARGATROBAN DOSE REQUIREMENTS IN INTENSIVE CARE UNIT PATIENTS
Koessler J.	-	CROSS-TALK OF VWF/GPIB- AND NO/CGMP-INDUCED SIGNALING IN HUMAN PLATELETS
Koga S.	-	CLINICAL SIGNIFICANCE OF HMGB-1, SF AND PAI-1 AS A VITAL- PROGNOSIS MARKER
Kogushi M.	-	EFFECTS OF E5555, A PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONIST, ON THE INFLAMMATORY MARKERS IN VITRO
Koh C.Y.	-	VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
Koh P.L.	-	GASTROINTESTINAL BLEEDING DUE TO MECKEL'S DIVERTICULUM IN A HEMOPHILIAC WITH INHIBITORS
Koh K.H.	-	LIVING DONOR LIVER TRANSPLANTATION FOR HBV-ASSOCIATED HEPATOMA IN A HEMOPHILIC PATIENT
Koh R.	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Koh S.C.L.	-	HUMAN TISSUE KALLIKREINS, HK6 AND HK10 AS NOVEL BIOMARKERS FOR EPITHELIAL OVARIAN CANCER
Koh A.	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Koh L.B.	-	PLATELET ADHESION STUDIES ON NANOSTRUCTURED POLY (LACTIC-CO-GLYCOLIC ACID) CARBON NANOTUBE COMPOSITE
Koh A.	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
Kohl M.	-	BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
Kohler H.	-	COUNTS OF CD14++CD16+ MONOCYTES PREDICT CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS
Kohler H.P.	-	DEVELOPMENT OF MONOCLONAL ANTIBODIES FOR DIRECT DETECTION OF FACTOR XIII ACTIVATION PEPTIDE IN PLASMA
	-	IS HETEROZYGOUS FACTOR XIII DEFICIENCY ASSOCIATED WITH PREGNANCY LOSS? A CASE REPORT
Kohlerova S.	-	RFVIIA IS EFFECTIVE ALTERNATIVE TO APCC IN PROPHYLAXIS OF BLEEDING DURING IMMUNE TOLERANCE PROTOCOL IN HAEMOPHILIAC WITH INHIBITOR
	-	IS IT POSSIBLE TO TREAT SAFELY AND EFFECTIVELY DEEP VEIN THROMBOSIS WITH CONTINUOUS I.V. INFUSION OF LMWH IN CHILDREN?
Koide T.	-	ACTIVATION OF ANTITHROMBIN BY SEQUENTIAL DELETION OF TWO AND THREE SUCCESSIVE RESIUES IN THE C-TERMIANL REGION OF THE REACTIVE CENTER LOOP
Koike T.	-	DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
	-	THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
Koivisto P.A.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Kojima H.	-	POSSIBLE INVOLVEMENT OF CD226 IN CELLULAR INTERACTION OF MEGAKARYOCYTES WITH ENDOTHELIAL CELLS DURING MEGAKARYOPOIESIS AND PLATELET PRODUCTION
	-	ROLE OF THE PROAPOPTOTIC BH3-ONLY PROTEIN BIM IN MEGAKARYOPOIESIS AND PLATELET PRODUCTION
Kojima T.	-	DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Kojima K.	-	QUANTIFICATION OF BLOOD COAGULATION FACTOR XIII ANTIGEN BY LATEX IMMUNOTURBIDIMETRIC ASSAY
Kojima T.	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
	-	ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
Kojima Y.	-	RESIDUES 311-325 ON THE HEAVY CHAIN OF FVA REPRESENT AN ACTIVATED PROTEIN C BINDING REGION
Kojima T.	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Kok S.W.	-	DIRECT THROMBUS IMAGING WITH MAGNETIC RESONANCE IN THE DISCRIMINATION BETWEEN ACUTE AND CHRONIC DEEP VEIN THROMBOSIS; A PROSPECTIVE PROOF-OF-PRINCIPLE STUDY
Kokame K.	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
	-	ACTIVITIES AND POLYMORPHISMS OF ADAMTS13 IN THE JAPANESE GENERAL POPULATION
	-	THE DISTAL CARBOXYL-TERMINAL DOMAINS OF ADAMTS13 ARE REQUIRED IN VIVO FOR EFFICIENT CLEAVAGE OF VON WILLEBRAND FACTOR UNDER PROTHROMBOTIC CONDITIONS
Kokarovtseva S.N.	-	PREVALENCE OF FACTOR V LEIDEN, PROTHROMBIN G20210A, AND 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE MUTATIONS IN A HEALTHY RUSSIAN POPULATION
Kokubo Y.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
	-	ACTIVITIES AND POLYMORPHISMS OF ADAMTS13 IN THE JAPANESE GENERAL POPULATION
	-	AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
Kolaitis N.I.	-	ON THREE CASES OF INHERITABLE FACTOR VII DEFICIENCY
	-	A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS
Kolck U.W.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Kolesnikova I.N.	-	A FIBRIN-SPECIFIC MONOCLONAL ANTIBODY WITH EPITOPE LOCALIZED IN FIBRIN FRAGMENT BBETA118-134: ITS APPLICATION TO QUANTIFICATION OF SOLUBLE FIBRIN
Kolev K.	-	THE KINETICS OF TPA ACTIVACTION AND INHIBTION BY PAI-1 IN FIBRIN
	-	STUDY OF THE STRUCTURAL DETERMINANTS OF ARTERIAL VESSEL WALL THROMBOGENICITY
Koliou P.	-	ON THREE CASES OF INHERITABLE FACTOR VII DEFICIENCY
Kollars M.	-	ENDOGENOUS THROMBIN POTENTIAL IN PREGNANT WOMEN RECEIVING LOW MOLECULAR WEIGHT HEPARIN (LMWH)
	-	COMPARISON OF DIFFERENT METHODS FOR ISOLATION AND STORAGE OF MICROPARTICLES FROM HUMAN BLOOD
	-	CISPLATIN INDUCES IN VITRO THROMBIN GENERATION VIA FORMATION OF PROCOAGULANT ENDOTHELIAL MICROPARTICLES
Köller U.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Kolovratova V.	-	SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
Komada Y.	-	LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
	-	PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
Komanasin N.	-	FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS
Komáromi I.	-	MOLECULAR MECHANISM OF INTERACTION BETWEEN ACTIVATED FACTOR XIII AND ITS ACYL DONOR PEPTIDE SUBSTRATE
	-	TWO NOVEL MISSENSE MUTATIONS (THR233MET AND TRP308LEU) IN THE FACTOR X GENE AND THEIR FUNCTIONAL CONSEQUENCES IN A PATIENT WITH SEVERE FACTOR X DEFICIENCY
Komarov A.	-	D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS
Komisarenko S.V.	-	A FIBRIN-SPECIFIC MONOCLONAL ANTIBODY WITH EPITOPE LOCALIZED IN FIBRIN FRAGMENT BBETA118-134: ITS APPLICATION TO QUANTIFICATION OF SOLUBLE FIBRIN
Komisarenko S.	-	TGFBETA1 IS RESPONSIBLE FOR HIGH-GLUCOSE-INDUCED ENRICHMENT OF PERICELLULAR MATRIX WITH HYALURONIC ACID. DIFFERENT MECHANISMS FOR ENDOTHELIAL AND MESANGIAL CELLS
Komorowicz E.	-	STUDY OF THE STRUCTURAL DETERMINANTS OF ARTERIAL VESSEL WALL THROMBOGENICITY
Komorowski P.	-	DIAMOND PARTICLES OF MICROMETRIC SIZE ARE INTERNALIZED BY ENDOTHELIAL CELLS
Kondo H.	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Kondo K.	-	THE EFFECTS OF BLOCKING P2Y12 RECEPTOR IN ARTEROSCLEROSIS PRODUCED BY MURINE ALLO-TRANSPALANTATION
Kondo H.	-	GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
Koneti Rao A.	-	PHORBOL 12-MYRISTATE 13-ACETATE (PMA) RESPONSIVE SEQUENCE IN G ALPHA Q PROMOTER DURING MEGAKAYOCYTIC DIFFERENTIATION: REGULATION BY EGR-1
Kongstad O.	-	ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE
König V.	-	EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
Königs C.	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
	-	POTENTIAL USE OF LIGANDS TO FVIII INHIBITORS
Konkle B.A.	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Kono T.	-	DOES DIFFERENT D-DIMER LEVEL REDUCE THE USE OF VENOUS DUPLEX SCANNING TO RULE OUT DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM?
	-	THE UTILITY OF QUANTITATIVE CALF MUSCLE NEARINFRARED SPECTROSCOPY IN THE FOLLOWUP OF ACUTE DEEP VEIN THROMBOSIS
	-	PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
Konopatskaya O.	-	REDUNDANT AND NON-REDUNDANT ROLES FOR CLASSICAL PKC ISOFORMS IN THE REGULATION OF PLATELET FUNCTION
Konrad I.	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
Konstantinidis K.	-	THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE
Konstantinov K.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Kontothanassis D.	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Kooi E.	-	MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT
Kooner J.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Kooperberg C.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
Koos R.	-	Circulating inactive human Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular disease
Kooter I.M.	-	LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB
	-	THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS
Kopp S.	-	FUNCTIONAL COAGULATION ANALYSIS IN PATIENTS WITH BLOOD COAGULATION DISORDERS OR HYPERCOAGULABILITY: SIGNIFICANCE OF WHOLE BLOOD ROTATION THROMBELASTOGRAPHY IN COMPARISON WITH CONVENTIONAL BLOOD COAGULATION ANALYSIS
Kopylov K.	-	TRANSITION TO STANDARD HAEMOSTATIC THERAPY SCHEMES OF HEMOPHILIA IN RUSSIA (THE NATIONAL TREATMENT PROTOCOL FOR HEMOPHILIA PATIENTS)
Kopylov K.G.	-	HOME TREATMENT WITH RECOMBINANT VIIA FACTOR IN HEMOPHILIA PATIENTS WITH INHIBITOR
Korantzis I.	-	SECONDARY THROMBOPHYLAXIS USING ANTIPLATELET AGENTS AND LONG TERM MONITORING AFTER 1ST UNPROVOKED EPISODE OF VENOUS THROMBOEMBOLISM
Koren-Morag N.	-	A DECREASED INCIDENCE RATE OF ISCHEMIC STROKE IN PATIENTS WITH SEVERE FACTOR XI DEFICIENCY SUGGESTS THAT THE DEFICIENCY CONFERS PROTECTION
Korndörfer M.	-	FIBRIN-MEDIATED THROMBUS FIXATION TO ENDOTHELIUM LEADS TO MONOLAYER DISRUPTION AFTER SHEAR INDUCED THROMBUS DISLODGEMENT
Kornecki E.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Körnicke T.	-	COADMINSTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND ATORVASTATIN HAS LITTLE IMPACT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EITHER DRUG
	-	NO INTERACTION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DIGOXIN
	-	COADMINISTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DICLOFENAC HAS LITTLE IMPACT ON THE PHARMACOKINETICS OF EITHER DRUG
Korporaal S.J.A.	-	LDL-INDUCED PLATELET ACTIVATION INVOLVES SPECIFIC DOMAINS IN APOB100
	-	ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
	-	EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS
Korsgren O.	-	ACTIVATION OF BLOOD COAGULATION IN AB0-COMPATIBLE BLOOD BY MULTIPOTENT MESENCHYMAL STROMAL CELLS
Korte W.C.	-	EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Korteweg F.J.	-	THROMBIN ACTIVATBLE FIBRINOLYSIS INHIBITOR (TAFI) IS NOT ASSOCIATED WITH FETAL LOSS; A RETROSPECTIVE STUDY
Korzh I.	-	SIGNIFICANCE OF PLASMA THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION
	-	SIGNIFICANCE OF LOW-GRADE INFLAMMATION MARKERS AND SOLUBLE CELL ADHESION MOLECULES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
	-	RELATIONSHIP BETWEEN OXIDATIVE STRESS, ENDOTHELIAL INJURY AND COAGULATION ACTIVATION IN ADVANCED CHRONIC HEART FAILURE
Korzh O.	-	ROLE OF ENDOTHELIAL CELL-DERIVED MICROPARTICLES IN PATIENTS WITH CHRONIC HEART FAILURE
	-	RELATIONSHIP BETWEEN CIRCULATING THROMBOMODULIN LEVELS AND LATENT PROGRESSION OF ATHEROSCLEROSIS IN TYPE 2 DIABETIC PATIENTS
	-	RELATIONSHIP BETWEEN ENDOTHELIAL HAEMOSTATIC MARKERS IN TYPE 2 DIABETIC PATIENTS
	-	EFFECT OF ATORVASTATIN ON MARKERS OF INFLAMMATION AND PLATELET AGGREGATION IN PATIENTS WITH CHRONIC HEART FAILURE
Kos C.	-	INACTIVE TISSUE FACTOR CONTAINING EXPOSED THIOLS RESIDES ON THE SURFACE OF UNSTIMULATED ENDOTHELIAL CELLS
Kos C.A.	-	CANCER-ASSOCIATED THROMBOSIS: TISSUE FACTOR-BEARING MICROPARTICLES ARE ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLIC EVENTS IN CANCER PATIENTS
Koscielny J.	-	EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII (NOVOSEVEN) IN TRAUMA AND SURGERY PATIENTS WITH MASSIVE BLEEDING A REGISTER ANALYSIS
Koseki K.	-	THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Koshelev V.B.	-	HAEMOSTASIS AND FIBRINOLYSIS AFTER EXPERIMENTAL AUDIOGENIC SEIZURES/
Koshihara K.	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Koshimoto C.	-	PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH
Kostelansky M.S.	-	DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
Koster A.	-	ARGATROBAN IN PATIENTS AFTER CARDIOVASCULAR SURGERY: INFLUENCE ON A THROMBIN GENERATION ASSAY
Kostin S.	-	INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Kostova G.	-	PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE)
Kostovska S.	-	TREATMENT OF DIC AS A COMPLICATION OF POLYTRANSFUSION AT PATIENT WITH OBSTETRIC HEMORRHAGE-CASE REPORT
Kotchuev G.	-	EFFECT OF ATORVASTATIN ON MARKERS OF INFLAMMATION AND PLATELET AGGREGATION IN PATIENTS WITH CHRONIC HEART FAILURE
Kotlín R.	-	NEW HEREDITARY DYSFIBRINOGENEMIA AALPHA ASN106ASP ASSOCIATED WITH THROMBOSIS
Kotlyar E.	-	A NOVEL 'FIBRINOGEN-SPIKED' INR METHOD TO MONITOR WARFARIN IN A PATIENT WITH HYPO/DYSFIBRINOGENAEMIA (FIBRINOGEN DARLINGHURST)
Kotoucek P.	-	TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
Kotsi P.	-	CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
	-	COAGUCHEK XS IN COMPARISON TO BCS ANALYZER. RESULTS IN AN OUTPATIENT ANTICOAGULATION CLINIC, FOCUSED IN METAL VALVE DISEASE
	-	PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY
	-	SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
Kottke-Marchant K.	-	P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
	-	CLINICAL EXPERIENCE WITH PLATELET AGGREGATION TESTING FOR ASPIRIN AND CLOPIDOGREL
	-	INDETERMINATE RESULTS ARE COMMON IN LUPUS ANTICOAGULANT TESTING
Kotula-Horowitz K.	-	IMPROVEMENT OF THIOLACTONASE ACTIVITY OF PARAOXONASE 1 BY SIMVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
	-	ANTITHROMBOTIC AND ANTI-PLATELET EFFECTS LIPID-LOWERING DRUGS, HOMOCYSTEINE AND N-METHYLNICOTYNAMIDE PLASMA LEVELS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
Kotzsch M.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Kouides P.A.	-	MENORRHAGIA ASSOCIATED WITH LABORATORY ABNORMALITIES OF HEMOSTASIS: EPIDEMIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS
	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
Kouramba A.	-	CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
Kourounis G.	-	INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE
Kovac M.	-	HAEMOPHILIA TREATMENT IN SERBIA FROM 2000 TO 2006 HOW TO REACH ONE UNIT PER CAPITA IN LOW ECONOMIC CAPACITY COUNTRY
	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
	-	THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY
	-	THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE
Kovacs M.J.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
	-	REVERSE: RECURRENT VENOUS THROMBOEMBOLISM (VTE) RISK STRATIFICATION EVALUATION: A PROSPECTIVE COHORT STUDY TO DEVELOP A CLINICAL PREDICTION RULE TO IDENTIFY LOW RISK PATIENTS WHO CAN DISCONTINUE ORAL ANTICOAGULANTS (OAC) 5-7 MONTHS AFTER TREATMENT FOR IDI
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	FREQUENCY OF "SPECIAL POPULATION" CHARACTERISTICS IN VENOUS THROMBOEMBOLISM PATIENTS IN CLINICAL PRACTICE: EFFECT ON PATIENT MANAGEMENT
	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
Kovács A.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Kovacs M.J.	-	A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
	-	D-DIMER WHILE ON ORAL ANTICOAGULANTS (OAC) IS ASSOCIATED WITH SUBSEQUENT RECURRENT VENOUSTHROMBOEMBOLISM OFF OF OAC IN WOMEN BUT NOT MEN
	-	INFLUENCE OF GENDER AND AGE ON RISK OF RECURRENT VENOUSTHROMBOEMBOLISM (VTE) IN PATIENTS WITH IDIOPATHIC VTE TREATED 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY
	-	INTER-OBSERVER RELIABILITY OF MEASURES TO ASSESS THE POST-THROMBOTIC SYNDROME (PTS)
	-	POST-THROMBOTIC SYNDROME (PTS) SIGNS AND SYMPTOMS AT THE TIME OF DISCONTINING 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) IS ASSOCIATED WITH SUBSEQUENT RECURRENT VTE
	-	RESIDUAL VENOUS THROMBOSIS AFTER 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY AS A PREDICTOR OF SUBSEQUENT RECURRENT VENOUS THROMBOEMBOLISM VTE
	-	HYPERCHOLESTEROLEMIA IS STRONGLY ASSOCIATED WITH RISK OF RECURRENT VTE IN WOMEN TREATED FOR 5-7 MONTHS WITH ORAL ANTICOAGULANTS (OAC) FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE)
	-	PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
Kovalenko T.N.	-	NEUROPROTECTIVE EFFECTS OF QUERCETIN IN A GERBIL MODEL OF CEREBRAL ISCHEMIA
Kovalenko T.F.	-	PREVALENCE OF FACTOR V LEIDEN, PROTHROMBIN G20210A, AND 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE MUTATIONS IN A HEALTHY RUSSIAN POPULATION
Kovalenko T.N.	-	MODULATION OF NITRIC OXIDE PRODUCTION BY CULTURED ENDOTHELIAL CELLS
Kovaleva L.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Kovalova Z.	-	NATURAL CLEARANCE OF HEPATITIS C VIRUS INFECTION AND HUMAN LEUKOCYTE ANTIGEN CLASS II ALLELES IN CHILDREN WITH HAEMOPHILIA
Kövér K.	-	MOLECULAR MECHANISM OF INTERACTION BETWEEN ACTIVATED FACTOR XIII AND ITS ACYL DONOR PEPTIDE SUBSTRATE
Kowalska M.	-	PLATELET FACTOR 4 EXERTS A NEGATIVE PARACRINE EFFECT ON MEGAKARYOPOIESIS THROUGH LIPOPROTEIN RELATED PROTEIN RECEPTOR-1 ON MEGAKARYOCYTIC PRECURSORS
Kowalska M.A.	-	ENDOGENOUS PLATELET FACTOR 4 INCREASES ACTIVATED PROTEIN C GENERATION AND IMPROVES SURVIVAL AFTER LIPOPOLYSACCHARIDE CHALLENGE
Kownacki E.	-	EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Koy E.	-	PLATELET THROMBUS GROWTH ANGLE (PTGA) VERSUS CLOSURE TIME (CT) IN VON WILLEBRAND PATIENTS TYPE I AS MEASURED WITH THE PLATELET FUNCTION ANALYSER
Koyama T.	-	INTRACELLULAR DEGRADATION OF NATURALLY OCCURRING PROTEIN C (PC) MUTANTS
	-	1,25(OH)2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB
	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
Koyama N.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Koyasu S.	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
Kozak M.	-	MATRIX METALLOPROTEINASE-3, TISSUE INHIBITOR OF METALLOPROTEINASES-1 AND WARFARIN TREATMENT
Kozar E.	-	USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
Kozuma Y.	-	POSSIBLE INVOLVEMENT OF CD226 IN CELLULAR INTERACTION OF MEGAKARYOCYTES WITH ENDOTHELIAL CELLS DURING MEGAKARYOPOIESIS AND PLATELET PRODUCTION
	-	ROLE OF THE PROAPOPTOTIC BH3-ONLY PROTEIN BIM IN MEGAKARYOPOIESIS AND PLATELET PRODUCTION
Krakow E.F.	-	PLATELET FACTOR V DEFICIENCY IN A PATIENT WITH AN ACQUIRED INHIBITOR OF VA PROCOAGULANT FUNCTION
Kralj E.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Kramaric A.	-	QUALITY OF ANTICOAGULANT MANAGEMENT: A 4-YEAR ANALYSIS OF TREATMENT AND COMPLICATIONS IN ANTICOAGULATION SERVICE IN LJUBLJANA
Kramer M.H.H.	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Krämer B.	-	PLATELETS, INFLAMMATION AND ATHEROSCLEROSIS
Kramer M.	-	INHERITED THROMBOPHILIA AND PREECLAMPSIA WITHIN A COHORT OF 5337 WOMEN: RESULTS OF THE MONTREAL PREECLAMPSIA STUDY
Kramer M.H.H.	-	HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
Kramkowski K.	-	THE PROTHROMBOTIC AND HYPERTENSIVE EFFECTS OF ANGIOTENSIN(1-9) IN RATS MAY BE MEDIATED BY ANGIOTENSIN II
	-	N-METHYLNICOTINAMIDE INHIBITS ARTERIAL THROMBOSIS IN HYPERTENSIVE RATS
Krarup J.	-	IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
Krasnobryzha I.M.	-	THE NOVEL PROTEIN-PROTEIN INTERACTION IN MAMMALIAN HAEMOSTASIS SYSTEM INDUCING BY STREPTOKINASE
Krasnokutskiy S.	-	EFFECT OF ATORVASTATIN ON MARKERS OF INFLAMMATION AND PLATELET AGGREGATION IN PATIENTS WITH CHRONIC HEART FAILURE
	-	ROLE OF ENDOTHELIAL CELL-DERIVED MICROPARTICLES IN PATIENTS WITH CHRONIC HEART FAILURE
Kratzer M.A.A.	-	PLATELET DELAY TIME AS MEASURED IN THE ARTERIOLES OF RATS USING LASER INDUCED THROMBOSIS
	-	PLATELET THROMBUS GROWTH ANGLE (PTGA) VERSUS CLOSURE TIME (CT) IN VON WILLEBRAND PATIENTS TYPE I AS MEASURED WITH THE PLATELET FUNCTION ANALYSER
Kraul D.	-	PRELIMINARY PERFORMANCE DATA OF A NEW QUANTITATIVE AND SENSITIVE D-DIMER ASSAY
Kraus A.E.	-	RAP1B IS REQUIRED FOR NORMAL ANGIOGENESIS AND MAPK SIGNALING IN ENDOTHELIAL CELLS
Krause M.	-	FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
	-	RAPID INCREASE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HAEMOPHILIA AND CHRONIC HCV- INFECTION
	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
	-	RESPONSE TO RITUXIMAB AND EPITOPE MAPPING OF INHIBITORY ANTIBODIES IN ACQUIRED HAEMOPHILIA
	-	INFLUENCE OF ANTIEPILEPTIC DRUGS ON THE COAGULATION
Krauze-Brzósko K.	-	INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
Kravitz R.L.	-	IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
Krcova V.	-	TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN ACTIVATOR INHIBITOR-1 AND VON WILLEBRAND FACTOR IN THE ACUTE AND CONVALESCENT PHASE OF ISCHEMIC STROKE
	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	THROMBIN GENERATION TEST AN EXPERIENCE OF ONE CENTRE IN THROMBOPHILIA PATIENTS
	-	AGGREGATION TEST FOR DETECTION CLOPIDOGREL RESISTANCE
Krebs V.L.J.	-	NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER
Kreder H.J.	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Krediet R.T.	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
Krejci M.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Kremer Hovinga J.A.	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
	-	A ROLE OF THE ADAMTS13 GENE IN ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Kremer Hovinga J.	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Kremer Hovinga J.A.	-	CLINICAL ASPECTS OF HEREDITARY AND ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Kremer Hovinga J.A.K.	-	HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
Kret R.	-	LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
	-	THE THROMBIN GENERATION TEST NEEDS TO BE SUPPLEMENTED WITH ADDITIONAL TESTS TO FULLY DOCUMENT THE EFFECTS OF THROMBIN INHIBITORS: EVALUATION FOR MELAGATRAN
Kretschmer V.	-	PLATELET THROMBUS GROWTH ANGLE (PTGA) VERSUS CLOSURE TIME (CT) IN VON WILLEBRAND PATIENTS TYPE I AS MEASURED WITH THE PLATELET FUNCTION ANALYSER
Kretz C.A.	-	ANTICOAGULANT PROPERTIES OF HD1, A (PRO)THROMBIN-DIRECTED DNA APTAMER
Kreutz R.P.	-	INHIBITION OF PLATELET AGGREGATION: A NOVEL EFFECT OF C-REACTIVE PROTEIN
	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
Kreutz Y.	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
Kreutz R.P.	-	THE RELATION OF HIGH EX VIVO THROMBOGENIC POTENTIAL TO HIGH ISCHEMIC RISK IN AFRICAN AMERICAN WOMEN UNDERGOING CORONARY STENTING
	-	SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI
	-	BIOMARKER ANALYSIS BY FLUOROKINE MULTI-ANALYTE PROFILING DISTINGUISHES PATIENTS REQUIRING INTERVENTION FROM PATIENTS WITH LONG-TERM QUIESCENT CORONARY ARTERY DISEASE: A POTENTIAL APPROACH TO IDENTIFY ATHEROSCLEROTIC DISEASE PROGRESSION
	-	RELATION OF PLATELET-FIBRIN CLOT STRENGTH, PLATELET REACTIVITY, INFLAMMATION AND GROWTH FACTOR RELEASE TO THROMBOTIC RISK IN PATIENTS UNDERGOING STENTING
	-	TRANSITION TO AN UNSTABLE CORONARY SYNDROME IS MARKED BY HYPERCOAGUABILITY, PLATELET ACTIVATION, HEIGHTENED PLATELET REACTIVITY, AND INFLAMMATION: RESULTS OF THE THROMBOTIC RISK PROGRESSION (TRIP) STUDY
Kreutzer G.O.	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
Kreuz W.	-	RESPONSE TO RITUXIMAB AND EPITOPE MAPPING OF INHIBITORY ANTIBODIES IN ACQUIRED HAEMOPHILIA
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
	-	POTENTIAL USE OF LIGANDS TO FVIII INHIBITORS
	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
	-	EXPERIENCES IN THERAPY AND OUTCOME OF ADOLESCENTS WITH ACUTE VENOUS THROMBOSIS
Krieger D.	-	HEMODIALYSER MEMBRANES ALLOW FOR REMOVAL OF ARGATROBAN
Krilis S.A.	-	BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
Krishnamurthy S.	-	POTENTIAL ROLE OF RAPID MOLECULAR SCREENING OF PATIENTS WITH DYSFIBRINOGENEMIA
Krisinger M.J.	-	A COMPARISON OF THE MEMBRANE BINDING PROPERTIES OF THE GAMMA-CARBOXY GLUTAMIC ACID PROTEINS OF BLOOD COAGULATION
Kristensen S.R.	-	EPIDEMIOLOGICAL STUDY OF VENOUS THROMBOEMBOLISM IN A BIG DANISH COHORT
	-	TEST OF ASPIRIN RESISTANCE
	-	RESPONSE TO ASPIRIN AND CLOPIDOGREL IN HEALTHY MEN
Kristensen A.T.	-	NEEDLE INDUCED HAEMARTHROSIS: A MURINE MODEL OF HEMOPHILIC SYNOVITIS
Kristensen S.R.	-	LATE BREAKING CLINICAL TRIALS- BIOPHYSICAL INVESTIGATION OF A CONFORMATIONAL DISEASE: ANTITHROMBIN III AALBORG
Kristensen A.T.	-	EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
	-	PROSPECTIVE DESIGN OF A NEW, OBJECTIVE SCORING SYSTEM FOR IDENTIFYING DISSEMINATED INTRAVASCULAR COAGULATION IN DOGS A SPONTANEOUS ANIMAL MODEL
Kritz H.	-	PLATELET RESPONSE DOES NOT CHANGE DURING LONG-TERM-TREATMENT (8YEARS) WITH 50 OR 100 MG ACETYLSALICYLIC ACID (ASA) FOR SECONDARY PREVENTION
Kriukov A.	-	ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS)
Krivosic V.	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
Kriz R.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Kroeger K.	-	EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
Kroese A.	-	BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
Krogh T.N.	-	IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
Krogh-Meibom T.	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
Kroh H.K.	-	VON WILLEBRAND FACTOR BINDING PROTEIN IS A NOVEL CONFORMATIONAL ACTIVATOR OF PROTHROMBIN
Krolicki L.	-	EVALUATION OF EFFICACY OF RADIOACTIVE SYNOVECTOMY IN RECURRENT JOINT BLEEDING IN HAEMOPHILIA
Kroll H.	-	HEPARIN INDEPENDENT ACTIVATION OF PLATELETS BY HIT ANTIBODIES. A COMMON OCCURRENCE
	-	CUTANEOUS DELAYED-TYPE IV-HYPERSENSITIVITY REACTION (DTH) TO HEPARIN AND HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II (HIT) IS THERE AN ASSOCIATION ?
	-	SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES
	-	HETEROGENEITY OF HPA-3 ALLOANTIBODIES: CONSEQUENCES FOR THE DIAGNOSIS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Kroon A.A.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS
Kropacheva E.	-	INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
Krougliak V.	-	LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
Kruchinsky N.G.	-	IMAGE ANALYSIS OF LYMPHOCYTES CHROMATIN AT THE APOPTOSIS
	-	CORRECTION HAEMOSTASIOLOGIC AND RHEOLOGIC DISTURBANCES AT THE PATIENTS WITH ISCHEMIC HEART AND BRAIN DESIASES BY MEANS OF COMBINATION OF PHARMACOLOGICAL DRUGS AND EXTRACORPOREAL AUTOBLOOD-MAGNET-THERAPY
Kruessel J.S.	-	RISK DETERMINANTS OF ARTERIAL THROMBOSIS INCREASE THE RISK OF INTRAUTERINE GROWTH RESTRICTION (IGR)
Kruger A.	-	ALCOHOL CONSUMPTION IS NOT ASSOCIATED WITH FIBRINOGEN IN A LARGE POPULATION OF AFRICAN BLACKS
Krugluger W.	-	REVERSE-HYBRIDIZATION-BASED GENETIC TESTING FOR THE PREDICTION OF ANTICOAGULANT DOSE REQUIREMENT
Kruijswijk E.	-	COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
Kruip M.J.H.A.	-	HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Kruip M.J.H.M.	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Kruip M.J.H.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
Kruithof E.K.O.	-	A COMPARATIVE ANALYSIS OF THE RESPONSE TO INFLAMMATORY STIMULI OF BLOOD- AND MESENCHYMAL STEM CELLDERIVED ENDOTHELIAL PROGENITOR CELLS
	-	THE REGULATION OF ENDOTHELIAL CELL T-PA PRODUCTION BY FLUVASTATIN
	-	ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES
	-	DIFFERENCES IN ENDOTHELIAL CELL ACTIVATION BY IGG FROM PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME OR WITH IMMUNE THROMBOCYTOPENIC PURPURA
	-	FLUVASTATIN INHIBITS REGULATED SECRETION OF ENDOTHELIAL CELL VON WILLEBRAND FACTOR IN RESPONSE TO DIVERSE SECRETAGOGUES
Krümpel A.	-	ROLE OF ELEVATED ALPHA2-MACROGLOBULIN REVISITED: RESULTS OF A CASE-CONTROL STUDY IN CHILDREN WITH SYMPTOMATIC THROMBOEMBOLISM
Krumwiede M.D.	-	THE CRITICAL ROLE OF MYOSIN IIA IN PLATELET INTERNAL CONTRACTION
Kruse-Jarres R.	-	DDAVP VERSUS VWF-CONTAINING FACTOR CONCENTRATE IN A PATIENT WITH ACQUIRED VON WILLEBRAND SYNDROME (AVWS) ASSOCIATED WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	THE ROLE OF RACE AND ETHNICITY IN THE CLINICAL OUTCOMES OF SEVERE HEMOPHILIA A PATIENTS WITH INHIBITORS
Krusius T.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Ku G.	-	VENOUS THROMBOEMBOLISM IN ACUTE LEUKEMIA PATIENTS: INCIDENCE, RISK FACTORS, AND MORTALITY
Kubackova K.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Kubisz P.	-	STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
	-	ACQUIRED HAEMOPHILIA A WITH INHIBITOR - CASE REPORT
Kubitza D.	-	THE EFFECT OF AGE AND GENDER ON THE PHARMACOLOGY AND SAFETY OF THE ORAL, DIRECT FACTOR XA INHIBITOR RIVAROXABAN
	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR HAS NO CLINICALLY RELEVANT INTERACTION WITH ACETYLSALICYLIC ACID OR NAPROXEN
	-	EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
Kucharewicz I.	-	PLASMIN SYSTEM REGULATION IN OVA-SENSITIZED RAT MODEL OF ASTHMA
Kucherenko M.E.	-	EFFECTS OF 7 KDA STREPTOKINASE FRAGMENT ON THE RABBIT HAEMOSTASIS SYSTEM
Kuderer N.M.	-	DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR CHEMOTHERAPY-ASSOCIATED THROMBOSIS
	-	INCREASING RATE OF VENOUS THROMBOEMBOLISM AMONG HOSPITALIZED CANCER PATIENTS
Kudryavceva L.	-	TRANSITION TO STANDARD HAEMOSTATIC THERAPY SCHEMES OF HEMOPHILIA IN RUSSIA (THE NATIONAL TREATMENT PROTOCOL FOR HEMOPHILIA PATIENTS)
Kueter T.J.	-	GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
	-	TYROSINE KINASE SYK PLAYS A PIVOTAL ROLE IN PLATELET SIGNALING INITIATED BY PATHOPHYSIOLOGICAL SHEAR STRESS
Kuhle S.	-	RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY
	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
Kuhlisch E.	-	THE ANTICOAGULANT PROTEINS S AND ANTITHROMBIN DISPLAY REMARKABLE SEX-DEPENDENT CHANGES DURING AGING
Kuhn J.G.	-	EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS
Kuhn C.M.	-	PLATELET AGGREGATION AND SEROTONIN ACTIVITY
Kuijpers M.J.E.	-	INHIBITION OF P2Y12 BY AZD6140 REDUCES THROMBUS FORMATION AND PROCOAGULANT ACTIVITY ON COLLAGEN AND ATHEROSCLEROTIC PLAQUES
	-	VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
	-	CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION
Kuiper J.	-	EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS
Kuipers S.	-	THE ABSOLUTE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL: EFFECT OF RISK FACTORS AND BEHAVIOUR DURING FLIGHTS
	-	LONG DISTANCE TRAVEL AND RISK OF VENOUS THROMBOSIS: EFFECT OF PROCOAGULANT FACTOR LEVELS
	-	AIR TRAVEL AND VENOUS THROMBOSIS: A SYSTEMATIC REVIEW
Kujawski M.	-	DIFFERENTIATION OF LOW MOLECULAR WEIGHT HEPARINS AS STUDIED BY MOLECULAR WEIGHT PROFILE AND HEPARINASE-I DEPOLYMERIZATION: PHARMACOLOGIC IMPLICATIONS
	-	TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
Kuliczkowski W.	-	P2Y12 ANTAGONIST COMPLEMENTARY TO ASPIRIN THERAPY IS SUPERIOR TO ASPIRIN ALONE IN PATIENTS AFTER CARDIOSURGERY OPERATIONS
	-	THE METHODOLOGICAL PROBLEMS IN BLOOD PLATELET INVESTIGATION ARE STILL ACTUAL
	-	HOW TO EFFECTIVELY MEASURE THE INHIBITION OF THROMBOXANE GENERATION BY ASPIRIN IN WHOLE CITRATED BLOOD?
Kuliopulos A.	-	TUMOR-DERIVED CYR61 PROMOTES STROMAL MATRIX METALLOPROTEINASE PRODUCTION AND ANGIOGENESIS
	-	IDENTIFICATION OF A MICROTUBULE ASSOCIATED PROTEIN, BICAUDAL-D1, AS A NOVEL REGULATOR OF PAR1-G PROTEIN SIGNALING
Kulkarni R.	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY
Kulkarni V.	-	ZEBRAFISH: FROM HEMATOLOGY TO HYDROLOGY
Kulkarni R.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN
Kulkarni S.	-	HEME INDUCES TISSUE FACTOR EXPRESSION IN HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS: RELATIONSHIP TO CLINICAL HEMOLYTIC STATES
Kulkarni B.	-	CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS
Kulle B.	-	ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
Kulman J.D.	-	FUNCTIONAL CHARACTERIZATION OF PROLINE-RICH GLA PROTEINS (PRGPS) 1 AND 2
Kumar V.	-	DEFIBROTIDE MODULATES HEPARANASE EXPRESSION IN ENDOTHELIAL AND TUMOR CELLS: A POTENTIAL MECHANISM OF ACTION
Kumar S.	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
Kumar A.	-	N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX
Kummerle A.E.	-	NEW THIENYLACYLHYDRAZONE DERIVATIVES AS CYCLIC NUCLEOTIDES MODULATORS AND PLATELET AGGREGATION INHIBITORS
Kunapuli S.P.	-	ROLE OF PI-3 KINASE BETA ISOFORM ON ADP-INDUCED PLATELET RESPONSES
	-	NF-B REGULATES PLATELET PLC-2 EXPRESSION: STUDIES IN HUMAN PLATELET PLC-2 DEFICIENCY
	-	CBL-B: A PHYSIOLOGICALLY IMPORTANT SIGNALING MOLECULE FOR COLLAGEN-DEPENDENT ACTIVATION
	-	RHOA/P160ROCK PLAYS AN IMPORTANT ROLE IN THE DENSE GRANULE RELEASE OF PLATELETS
	-	REGULATION OF INSULIN-LIKE GROWTH FACTOR 1 IN PLATELET ACTIVATION
Kung C.	-	LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
Kunicki T.J.	-	INFLUENCE OF PLATELET GP6 HAPLOTYPES (GP6A AND GP6B)
	-	THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS
	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
Kunishima S.	-	DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
	-	ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
Kunnen J.	-	GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
Kunz S.	-	MONITORING OF ANTIPLATELET THERAPY BEFORE AND AFTER SURGICAL PROCEDURES IN PATIENTS WITH CORONARY STENTS
Kunzelmann C.	-	ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Kuo S.	-	REFERENCE RANGE OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY CHINESE
Kuo H.L.	-	ANTIPLATELET AND ANTITHROMBOTIC ACTIVITY OF NP-313, 2-ACETYLAMINO-3-CHLORO-1,4-NAPHTHOQUINONE, A NOVEL CPLA2 AND CYTOSOLIC CA 2 + MOBILIZATION INHIBITOR
Kuo S.C.	-	ANTIPLATELET AND ANTITHROMBOTIC ACTIVITY OF NP-313, 2-ACETYLAMINO-3-CHLORO-1,4-NAPHTHOQUINONE, A NOVEL CPLA2 AND CYTOSOLIC CA 2 + MOBILIZATION INHIBITOR
Kupesiz O.A.	-	TISSUE PLASMINOGEN ACTIVATOR (RTPA) INDUCED FIBRINOLYSIS - STANDARDIZATION OF METHOD ON THROMBELASTOGRAPHY
	-	FIBRINOLYTIC PARAMETERS IN CHILDREN WITH NON-CATHETER RELATED DEEP VENOUS THROMBOSIS
Kurachi S.	-	IDENTIFICATION OF ETS1 AS ASE BINDING PROTEIN: UNIQUE ROLE IN AGE-RELATED GENE REGULATION
Kurachi K.	-	IDENTIFICATION OF ETS1 AS ASE BINDING PROTEIN: UNIQUE ROLE IN AGE-RELATED GENE REGULATION
Kuranoff S.J.	-	SIGNIFICANT REDUCTION OF VASCULAR GRAFT OCCLUSIONS IN CHRONIC HEMODIALYSIS PATIENTS WITH PEG-HIRUDIN (SPP200)
Kuric L.	-	ACL TOP PERFORMANCE IN ROUTINE COAGULATION TESTING
Kurihara M.	-	INHIBITION OF CYTOSKELETAL ASSEMBLY BY CYTOCHALASIN D PREVENTS ENLARGEMENT OF RAFTS ACCOMPANIED BY GPVI ACCUMULATION IN COLLAGEN-STIMULATED PLATELETS
Kurnik K.	-	SECOND INTERIM ANALYSIS OF A LONG-TERM PHARMACOVIGILANCE PROJECT WITH A PLASMA DERIVED FVIII CONCENTRATE
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
	-	THE CHALLENGE OF PRAEOPERATIVE INVESTIGATION OF HEREDITARY AND ACQUIRED COAGULATION DISORDERS IN CHILDREN AND ADOLESCENTS
	-	THE PTT IS NOT ENOUGH PREOPERATIVE COAGULATION SCREENING IN CHILDREN
	-	EFFECTS OF THE FACTOR V G1691A MUTATION AND THE FACTOR II G20210A VARIANT ON THE CLINICAL EXPRESSION OF SEVERE HEMOPHILIA A ( 1%) IN CHILDREN
Kurokawa T.	-	THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
Kuroki A.	-	2-AG PLAY A ROLE ON ASPIRIN RESISTANCE IN TYPE 2 DIABETES
Kurt M.	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Kurth A.A.	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Kurth A.	-	PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
Kurtova A.V.	-	SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE
Kurum T.	-	INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
Kurz C.	-	PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE)
Kurz J.C.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Kushak R.	-	ACTIVE SITE-INHIBITED RFVIIA BLOCKS PLATELET STRING FORMATION ON INTACT ENDOTHELIUM ACTIVATED WITH TNF-ALPHA AND SHIGA TOXIN-1
Kushimoto S.	-	THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Kusumoto E.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Kuukka K.	-	SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
Kuuse S.	-	IMMUNE RESPONSE TO ADMINISTRATION OF PLASMA-DERIVED COAGULATION FACTOR VIII IN FACTOR VIII-DEFICIENT MICE
Kuzmanovic M.	-	RISK FACTORS FOR THROMBOSIS IN CHILDREN
Kuznik B.I.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
	-	POSSIBLE MECHANISMS OF THE DEVELOPMENT OF DIC SYNDROME
Kvasnicka J.	-	DECREASE OF SOLUBLE P-SELECTIN AND INHIBITION BOTH, ACTIVATED FACTOR XA AND THROMBIN AFTER I.V.ENOXAPARIN DURING PCI
Kvasnicka T.	-	DECREASE OF SOLUBLE P-SELECTIN AND INHIBITION BOTH, ACTIVATED FACTOR XA AND THROMBIN AFTER I.V.ENOXAPARIN DURING PCI
Kveder T.	-	ENDOTHELIAL FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND HISTORY OF VENOUS THROMBOSIS
Kwaan H.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Kwack K.	-	ANTITHROMBOTIC EFFECT OF RECOMBINANT DISINTEGRIN IN A MOUSE THROMBOSIS MODEL
Kwakkel-van Erp H.M.	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Kwik-Uribe C.	-	EFFECTS OF A FLAVANOL-RICH COCOA BEVERAGE ON PLATELET AND LEUCOCYTE FUNCTION IN MAN
Kwok W.W.	-	C2 DOMAIN T-CELL EPITOPES IN HEMOPHILIA A SUBJECTS WITH THE MUTATION A2201P
Kwon J.	-	IMPROVING RECOMBINANT FACTOR VIII (RFVIII) DOSING PRECISION IN THE TREATMENT OF HEMOPHILIA A RESULTS IN POTENTIAL COST SAVINGS
	-	EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Kwon B.	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Kwon H.	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Kwon M.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
Kyrle P.A.	-	RECURRENT VENOUS THROMBOEMBOLISM LINKED TO LOW PLASMA HDL
	-	SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP
Kyrle P.	-	6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS
Kyrle P.A.	-	CISPLATIN INDUCES IN VITRO THROMBIN GENERATION VIA FORMATION OF PROCOAGULANT ENDOTHELIAL MICROPARTICLES
	-	COMPARISON OF DIFFERENT METHODS FOR ISOLATION AND STORAGE OF MICROPARTICLES FROM HUMAN BLOOD
	-	ENDOGENOUS THROMBIN POTENTIAL IN PREGNANT WOMEN RECEIVING LOW MOLECULAR WEIGHT HEPARIN (LMWH)
	-	EXCESS BODY FAT AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
	-	CIRCULATING P-SELECTIN AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
	-	EFFECTS OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) ON RESTORING THROMBIN GENERATION IN PATIENTS WITH HEMOPHILIA A AND ANTIBODIES TO FACTOR VIII
Kyu P.S.	-	PHARMACO-ECONOMIC EVALUATION OF TREATMENT ALTERNATIVES FOR MILD TO MODERATE BLEEDING EPISODES IN PATIENTS WITH HAEMOPHILIA WITH INHIBITORS IN KOREA

| ISTH 2009